(lp0
(I-1
S'Cloning and characterization of two evolutionarily conserved subunits ( TFIIIC102 and TFIIIC63 ) of human TFIIIC and their involvement in functional interactions with TFIIIB and RNA polymerase III'
p1
(lp2
I9
a(lp3
I11
atp4
a(I-1
S'Cloning and characterization of two evolutionarily conserved subunits ( TFIIIC102 and TFIIIC63 ) of human TFIIIC and their involvement in functional interactions with TFIIIB and RNA polymerase III'
p5
(lp6
I9
a(lp7
I15
atp8
a(I-1
S'Cloning and characterization of two evolutionarily conserved subunits ( TFIIIC102 and TFIIIC63 ) of human TFIIIC and their involvement in functional interactions with TFIIIB and RNA polymerase III'
p9
(lp10
I11
a(lp11
I15
atp12
a(I1
S'Identification of residues in the monocyte chemotactic protein - 1 that contact the MCP - 1 receptor , CCR2'
p13
(lp14
I5
aI6
aI7
aI8
aI9
a(lp15
I18
atp16
a(I-1
S'The receptor binding site of MCP - 1 also is significantly different from the binding sites of RANTES and IL - 8 , providing insight into the issue of receptor specificity'
p17
(lp18
I5
aI6
aI7
a(lp19
I17
atp20
a(I-1
S'The receptor binding site of MCP - 1 also is significantly different from the binding sites of RANTES and IL - 8 , providing insight into the issue of receptor specificity'
p21
(lp22
I5
aI6
aI7
a(lp23
I19
aI20
aI21
atp24
a(I-1
S'The receptor binding site of MCP - 1 also is significantly different from the binding sites of RANTES and IL - 8 , providing insight into the issue of receptor specificity'
p25
(lp26
I17
a(lp27
I19
aI20
aI21
atp28
a(I1
S'It was previously shown that the N - terminus of CCR2 is critical for binding MCP - 1'
p29
(lp30
I10
a(lp31
I15
aI16
aI17
atp32
a(I1
S'To identify the regions of MCP - 1 that contact its receptor , CCR2 , we substituted all surface - exposed residues with alanine'
p33
(lp34
I5
aI6
aI7
a(lp35
I13
atp36
a(I-1
S'We tested this point by cotransfecting CHO cells with the genes encoding F beta alpha and the CG beta subunit or the CG beta alpha and FSH beta monomer'
p37
(lp38
I17
aI18
a(lp39
I22
aI23
aI24
atp40
a(I-1
S'We tested this point by cotransfecting CHO cells with the genes encoding F beta alpha and the CG beta subunit or the CG beta alpha and FSH beta monomer'
p41
(lp42
I17
aI18
a(lp43
I26
aI27
atp44
a(I-1
S'We tested this point by cotransfecting CHO cells with the genes encoding F beta alpha and the CG beta subunit or the CG beta alpha and FSH beta monomer'
p45
(lp46
I22
aI23
aI24
a(lp47
I26
aI27
atp48
a(I-1
S'The formation of a functional single chain / subunit complex was not restricted to the FSH single chain / CG beta subunit since CG single chain interacts with the monomeric FSH beta subunit and exhibits FSH activity'
p49
(lp50
I19
aI20
a(lp51
I30
aI31
atp52
a(I-1
S'This is relevant for the case of LH and FSH , because both are synthesized in the same cell ( i . e . , pituitary gonadotrophs ) and several of the alpha subunit sequences required for association with either the LH beta or FSH beta subunits are different'
p53
(lp54
I41
aI42
a(lp55
I44
aI45
atp56
a(I-1
S'Previously , we showed that the CG beta or FSH beta subunit genes can be genetically fused to the alpha gene to produce biologically active single chains , CG beta alpha and F beta alpha , respectively'
p57
(lp58
I6
aI7
a(lp59
I9
aI10
atp60
a(I-1
S'Previously , we showed that the CG beta or FSH beta subunit genes can be genetically fused to the alpha gene to produce biologically active single chains , CG beta alpha and F beta alpha , respectively'
p61
(lp62
I6
aI7
a(lp63
I28
aI29
aI30
atp64
a(I-1
S'Previously , we showed that the CG beta or FSH beta subunit genes can be genetically fused to the alpha gene to produce biologically active single chains , CG beta alpha and F beta alpha , respectively'
p65
(lp66
I9
aI10
a(lp67
I28
aI29
aI30
atp68
a(I1
S'Interleukin - 6 activates phosphatidylinositol - 3 kinase , which inhibits apoptosis in human prostate cancer cell lines'
p69
(lp70
I0
aI1
aI2
a(lp71
I4
aI5
aI6
aI7
atp72
a(I-1
S'RESULTS : Tyrosine phosphorylation of p85 is upregulated by IL - 6 in both LNCaP and PC - 3'
p73
(lp74
I9
aI10
aI11
a(lp75
I16
aI17
aI18
atp76
a(I1
S'IL - 6 promotes coprecipitation of p85 with gp130 , the signal - transducing component of the IL - 6 receptor'
p77
(lp78
I0
aI1
aI2
a(lp79
I8
atp80
a(I-1
S'IL - 6 promotes coprecipitation of p85 with gp130 , the signal - transducing component of the IL - 6 receptor'
p81
(lp82
I0
aI1
aI2
a(lp83
I17
aI18
aI19
aI20
atp84
a(I-1
S'IL - 6 promotes coprecipitation of p85 with gp130 , the signal - transducing component of the IL - 6 receptor'
p85
(lp86
I8
a(lp87
I17
aI18
aI19
aI20
atp88
a(I-1
S'In solution , FGFR4ed formed complexes with acidic FGF ( FGF - 1 ) and basic FGF ( FGF - 2 ) , both in the presence and absence of heparin'
p89
(lp90
I7
aI8
aI9
aI10
aI11
aI12
aI13
a(lp91
I15
aI16
aI17
aI18
aI19
aI20
aI21
atp92
a(I1
S'Immobilized FGFR4 also bound FGF - 8 besides FGF - 1 and FGF - 2'
p93
(lp94
I1
a(lp95
I4
aI5
aI6
atp96
a(I1
S'Immobilized FGFR4 also bound FGF - 8 besides FGF - 1 and FGF - 2'
p97
(lp98
I1
a(lp99
I8
aI9
aI10
atp100
a(I1
S'Immobilized FGFR4 also bound FGF - 8 besides FGF - 1 and FGF - 2'
p101
(lp102
I1
a(lp103
I12
aI13
aI14
atp104
a(I-1
S'Immobilized FGFR4 also bound FGF - 8 besides FGF - 1 and FGF - 2'
p105
(lp106
I4
aI5
aI6
a(lp107
I8
aI9
aI10
atp108
a(I-1
S'Immobilized FGFR4 also bound FGF - 8 besides FGF - 1 and FGF - 2'
p109
(lp110
I4
aI5
aI6
a(lp111
I12
aI13
aI14
atp112
a(I-1
S'Immobilized FGFR4 also bound FGF - 8 besides FGF - 1 and FGF - 2'
p113
(lp114
I8
aI9
aI10
a(lp115
I12
aI13
aI14
atp116
a(I1
S'Cytohesin - 1 regulates beta - 2 integrin - mediated adhesion through both ARF - GEF function and interaction with LFA - 1'
p117
(lp118
I0
aI1
aI2
a(lp119
I20
aI21
aI22
atp120
a(I1
S'Here we provide evidence of how cytohesin - 1 , an integrin - binding protein and guanine - nucleotide exchange factor ( GEF ) for ARF GTPases , regulates cell adhesion'
p121
(lp122
I6
aI7
aI8
a(lp123
I25
atp124
a(I1
S'Mutational analyses of the beta - 2 cytoplasmic domain revealed that the adhesive function of LFA - 1 depends on its interaction with cytohesin - 1 , unless the integrin is activated by exogenous divalent cations'
p125
(lp126
I15
aI16
aI17
a(lp127
I23
aI24
aI25
atp128
a(I1
S'Secondly , cytohesin - 1 induces expression of an extracellular activation epitope of LFA - 1 , and the exchange factor function is not essential for this activity'
p129
(lp130
I2
aI3
aI4
a(lp131
I13
aI14
aI15
atp132
a(I1
S'In contrast , LFA - 1 - mediated cell adhesion and spreading on intercellular cell adhesion molecule 1 is strongly inhibited by a cytohesin - 1 mutant , which fails to catalyze ARF GDP - GTP exchange in vitro'
p133
(lp134
I23
aI24
aI25
a(lp135
I32
atp136
a(I1
S'Thus , cytohesin - 1 is involved in the activation of LFA - 1 , most probably through direct interaction with the integrin , and induces cell spreading by its ARF - GEF activity'
p137
(lp138
I2
aI3
aI4
a(lp139
I11
aI12
aI13
atp140
a(I-1
S'Regulation of neutrophil adhesion by pituitary growth hormone accompanies tyrosine phosphorylation of Jak2 , p125FAK , and paxillin'
p141
(lp142
I12
a(lp143
I17
atp144
a(I-1
S'These results suggest that pituitary GH modulates neutrophil adhesion through tyrosine phosphorylation of Jak2 , p125FAK , and paxillin and actin polymerization'
p145
(lp146
I13
a(lp147
I18
atp148
a(I-1
S'Pituitary GH triggered the tyrosine phosphorylation of Janus kinase 2 ( Jak2 ) and STAT3 in neutrophils'
p149
(lp150
I7
aI8
aI9
a(lp151
I11
atp152
a(I-1
S'Pituitary GH triggered the tyrosine phosphorylation of Janus kinase 2 ( Jak2 ) and STAT3 in neutrophils'
p153
(lp154
I7
aI8
aI9
a(lp155
I14
atp156
a(I-1
S'Pituitary GH triggered the tyrosine phosphorylation of Janus kinase 2 ( Jak2 ) and STAT3 in neutrophils'
p157
(lp158
I11
a(lp159
I14
atp160
a(I-1
S'Preincubation with genistein , a tyrosine kinase inhibitor , blocked the GH - stimulated adhesion and Jak2 , STAT3 , p125FAK , and paxillin phosphorylation'
p161
(lp162
I16
a(lp163
I18
atp164
a(I-1
S'Preincubation with genistein , a tyrosine kinase inhibitor , blocked the GH - stimulated adhesion and Jak2 , STAT3 , p125FAK , and paxillin phosphorylation'
p165
(lp166
I16
a(lp167
I23
atp168
a(I-1
S'Preincubation with genistein , a tyrosine kinase inhibitor , blocked the GH - stimulated adhesion and Jak2 , STAT3 , p125FAK , and paxillin phosphorylation'
p169
(lp170
I18
a(lp171
I23
atp172
a(I1
S'Immunoprecipitation experiments revealed a physical association of Jak2 with p125FAK via STAT3 in vivo'
p173
(lp174
I7
a(lp175
I11
atp176
a(I1
S'Suppression of rat thromboxane synthase gene transcription by peroxisome proliferator - activated receptor gamma in macrophages via an interaction with NRF2'
p177
(lp178
I8
aI9
aI10
aI11
aI12
aI13
a(lp179
I20
atp180
a(I-1
S'Deletion analysis showed that the element responsible for the PPARgamma effect is located in a region containing the nuclear factor E2 ( NF - E2 ) / AP - 1 site ( - 98 / - 88 ) , which was indicated to be the major promoter of the TXS gene'
p181
(lp182
I22
aI23
aI24
a(lp183
I27
aI28
aI29
atp184
a(I-1
S'By electrophoretic mobility shift assay using the NF - E2 / AP - 1 site and nuclear extracts from macrophages , we observed a specific protein - DNA complex formation , which was inhibited by a specific antibody against the transcription factor NRF2 ( NF - E2 - related factor 2 )'
p185
(lp186
I7
aI8
aI9
a(lp187
I11
aI12
aI13
atp188
a(I-1
S'By electrophoretic mobility shift assay using the NF - E2 / AP - 1 site and nuclear extracts from macrophages , we observed a specific protein - DNA complex formation , which was inhibited by a specific antibody against the transcription factor NRF2 ( NF - E2 - related factor 2 )'
p189
(lp190
I7
aI8
aI9
a(lp191
I42
atp192
a(I-1
S'By electrophoretic mobility shift assay using the NF - E2 / AP - 1 site and nuclear extracts from macrophages , we observed a specific protein - DNA complex formation , which was inhibited by a specific antibody against the transcription factor NRF2 ( NF - E2 - related factor 2 )'
p193
(lp194
I7
aI8
aI9
a(lp195
I44
aI45
aI46
aI47
aI48
aI49
aI50
atp196
a(I-1
S'By electrophoretic mobility shift assay using the NF - E2 / AP - 1 site and nuclear extracts from macrophages , we observed a specific protein - DNA complex formation , which was inhibited by a specific antibody against the transcription factor NRF2 ( NF - E2 - related factor 2 )'
p197
(lp198
I11
aI12
aI13
a(lp199
I42
atp200
a(I-1
S'By electrophoretic mobility shift assay using the NF - E2 / AP - 1 site and nuclear extracts from macrophages , we observed a specific protein - DNA complex formation , which was inhibited by a specific antibody against the transcription factor NRF2 ( NF - E2 - related factor 2 )'
p201
(lp202
I11
aI12
aI13
a(lp203
I44
aI45
aI46
aI47
aI48
aI49
aI50
atp204
a(I-1
S'By electrophoretic mobility shift assay using the NF - E2 / AP - 1 site and nuclear extracts from macrophages , we observed a specific protein - DNA complex formation , which was inhibited by a specific antibody against the transcription factor NRF2 ( NF - E2 - related factor 2 )'
p205
(lp206
I42
a(lp207
I44
aI45
aI46
aI47
aI48
aI49
aI50
atp208
a(I-1
S'Finally , a direct interaction between PPARgamma and NRF2 was confirmed by glutathione S - transferase pull - down assay'
p209
(lp210
I8
a(lp211
I12
aI13
aI14
aI15
atp212
a(I-1
S'By constructing deletion mutants , we identified that amino acid residues 229 - 309 of Akt were involved in the binding to Hsp90 and amino acid residues 327 - 340 of Hsp90beta were involved in the binding to Akt'
p213
(lp214
I22
a(lp215
I31
atp216
a(I-1
S'Here , we cloned and characterized a mouse orthologue of human KIAA1427 protein as an atypical Syt ( named Syt XIII )'
p217
(lp218
I11
a(lp219
I16
atp220
a(I-1
S'Here , we cloned and characterized a mouse orthologue of human KIAA1427 protein as an atypical Syt ( named Syt XIII )'
p221
(lp222
I11
a(lp223
I19
aI20
atp224
a(I-1
S'Here , we cloned and characterized a mouse orthologue of human KIAA1427 protein as an atypical Syt ( named Syt XIII )'
p225
(lp226
I16
a(lp227
I19
aI20
atp228
a(I-1
S'Subcellular fractionation and antibody - uptake experiments indicate that Syt XIII is indeed a type - I membrane protein , but , unlike other Syt isoforms , lacks an N - terminal extracellular domain'
p229
(lp230
I9
aI10
a(lp231
I24
atp232
a(I1
S'Cutting edge : CD43 functions as a T cell counterreceptor for the macrophage adhesion receptor sialoadhesin ( Siglec - 1 )'
p233
(lp234
I3
a(lp235
I15
atp236
a(I1
S'Cutting edge : CD43 functions as a T cell counterreceptor for the macrophage adhesion receptor sialoadhesin ( Siglec - 1 )'
p237
(lp238
I3
a(lp239
I17
aI18
aI19
atp240
a(I-1
S'Cutting edge : CD43 functions as a T cell counterreceptor for the macrophage adhesion receptor sialoadhesin ( Siglec - 1 )'
p241
(lp242
I15
a(lp243
I17
aI18
aI19
atp244
a(I-1
S'The 130 - and 240 - kDa sialoadhesin - binding glycoproteins were identified as the sialomucins CD43 and P - selectin glycoprotein ligand 1 ( CD162 ) , respectively'
p245
(lp246
I16
a(lp247
I18
aI19
aI20
aI21
aI22
aI23
atp248
a(I-1
S'The 130 - and 240 - kDa sialoadhesin - binding glycoproteins were identified as the sialomucins CD43 and P - selectin glycoprotein ligand 1 ( CD162 ) , respectively'
p249
(lp250
I16
a(lp251
I25
atp252
a(I-1
S'The 130 - and 240 - kDa sialoadhesin - binding glycoproteins were identified as the sialomucins CD43 and P - selectin glycoprotein ligand 1 ( CD162 ) , respectively'
p253
(lp254
I18
aI19
aI20
aI21
aI22
aI23
a(lp255
I25
atp256
a(I1
S'CD43 expressed in COS cells supported increased binding to immobilized sialoadhesin'
p257
(lp258
I0
a(lp259
I10
atp260
a(I1
S'Finally , sialoadhesin bound different glycoforms of CD43 expressed in Chinese hamster ovary cells , including unbranched ( core 1 ) and branched ( core 2 ) O : - linked glycans , that are normally found on CD43 in resting and activated T cells , respectively'
p261
(lp262
I2
a(lp263
I7
atp264
a(I-1
S'Finally , sialoadhesin bound different glycoforms of CD43 expressed in Chinese hamster ovary cells , including unbranched ( core 1 ) and branched ( core 2 ) O : - linked glycans , that are normally found on CD43 in resting and activated T cells , respectively'
p265
(lp266
I2
a(lp267
I38
atp268
a(I-1
S'Finally , sialoadhesin bound different glycoforms of CD43 expressed in Chinese hamster ovary cells , including unbranched ( core 1 ) and branched ( core 2 ) O : - linked glycans , that are normally found on CD43 in resting and activated T cells , respectively'
p269
(lp270
I7
a(lp271
I38
atp272
a(I1
S'These results identify CD43 as a T cell counterreceptor for sialoadhesin and suggest that in addition to its anti - adhesive role CD43 may promote cell - cell interactions'
p273
(lp274
I3
a(lp275
I10
atp276
a(I-1
S'These results identify CD43 as a T cell counterreceptor for sialoadhesin and suggest that in addition to its anti - adhesive role CD43 may promote cell - cell interactions'
p277
(lp278
I3
a(lp279
I22
atp280
a(I-1
S'These results identify CD43 as a T cell counterreceptor for sialoadhesin and suggest that in addition to its anti - adhesive role CD43 may promote cell - cell interactions'
p281
(lp282
I10
a(lp283
I22
atp284
a(I1
S'Direct interaction between the cytoplasmic tail of ADAM 12 and the Src homology 3 domain of p85alpha activates phosphatidylinositol 3 - kinase in C2C12 cells'
p285
(lp286
I7
aI8
a(lp287
I16
atp288
a(I1
S'Direct interaction between the cytoplasmic tail of ADAM 12 and the Src homology 3 domain of p85alpha activates phosphatidylinositol 3 - kinase in C2C12 cells'
p289
(lp290
I7
aI8
a(lp291
I18
aI19
aI20
aI21
atp292
a(I1
S'Direct interaction between the cytoplasmic tail of ADAM 12 and the Src homology 3 domain of p85alpha activates phosphatidylinositol 3 - kinase in C2C12 cells'
p293
(lp294
I16
a(lp295
I18
aI19
aI20
aI21
atp296
a(I1
S'This suggests that transmembrane ADAM 12 , by providing docking sites for the Src homology 3 domain of p85alpha , activates PI 3 - kinase by mediating its recruitment to the membrane'
p297
(lp298
I4
aI5
a(lp299
I18
atp300
a(I1
S'AP180 binds to the C - terminal SH2 domain of phospholipase C - gamma1 and inhibits its enzymatic activity'
p301
(lp302
I0
a(lp303
I10
aI11
aI12
aI13
atp304
a(I1
S'In this report , we demonstrate the stable association of PLCgamma1 with AP180 in a clathrin - coated vesicle complex , which not only binds to the carboxyl - terminal SH2 domain of PLCgamma1 , but also inhibits its enzymatic activity in a dose - dependent manner'
p305
(lp306
I10
a(lp307
I12
atp308
a(I-1
S'In this report , we demonstrate the stable association of PLCgamma1 with AP180 in a clathrin - coated vesicle complex , which not only binds to the carboxyl - terminal SH2 domain of PLCgamma1 , but also inhibits its enzymatic activity in a dose - dependent manner'
p309
(lp310
I10
a(lp311
I33
atp312
a(I1
S'In this report , we demonstrate the stable association of PLCgamma1 with AP180 in a clathrin - coated vesicle complex , which not only binds to the carboxyl - terminal SH2 domain of PLCgamma1 , but also inhibits its enzymatic activity in a dose - dependent manner'
p313
(lp314
I12
a(lp315
I33
atp316
a(I1
S'Here we demonstrate colocalization and direct interaction between CLIP - 170 and LIS1'
p317
(lp318
I8
aI9
aI10
a(lp319
I12
atp320
a(I1
S'Overexpression of CLIP - 170 results in a zinc finger - dependent localization of a phospho - LIS1 isoform and dynactin to MT bundles , raising the possibility that CLIP - 170 and LIS1 regulate dynein / dynactin binding to MTs'
p321
(lp322
I2
aI3
aI4
a(lp323
I15
aI16
aI17
atp324
a(I-1
S'Overexpression of CLIP - 170 results in a zinc finger - dependent localization of a phospho - LIS1 isoform and dynactin to MT bundles , raising the possibility that CLIP - 170 and LIS1 regulate dynein / dynactin binding to MTs'
p325
(lp326
I2
aI3
aI4
a(lp327
I29
aI30
aI31
atp328
a(I-1
S'Overexpression of CLIP - 170 results in a zinc finger - dependent localization of a phospho - LIS1 isoform and dynactin to MT bundles , raising the possibility that CLIP - 170 and LIS1 regulate dynein / dynactin binding to MTs'
p329
(lp330
I2
aI3
aI4
a(lp331
I33
atp332
a(I-1
S'Overexpression of CLIP - 170 results in a zinc finger - dependent localization of a phospho - LIS1 isoform and dynactin to MT bundles , raising the possibility that CLIP - 170 and LIS1 regulate dynein / dynactin binding to MTs'
p333
(lp334
I15
aI16
aI17
a(lp335
I29
aI30
aI31
atp336
a(I-1
S'Overexpression of CLIP - 170 results in a zinc finger - dependent localization of a phospho - LIS1 isoform and dynactin to MT bundles , raising the possibility that CLIP - 170 and LIS1 regulate dynein / dynactin binding to MTs'
p337
(lp338
I15
aI16
aI17
a(lp339
I33
atp340
a(I-1
S'Overexpression of CLIP - 170 results in a zinc finger - dependent localization of a phospho - LIS1 isoform and dynactin to MT bundles , raising the possibility that CLIP - 170 and LIS1 regulate dynein / dynactin binding to MTs'
p341
(lp342
I29
aI30
aI31
a(lp343
I33
atp344
a(I1
S'This work suggests that LIS1 is a regulated adapter between CLIP - 170 and cytoplasmic dynein at sites involved in cargo - MT loading , and / or in the control of MT dynamics'
p345
(lp346
I4
a(lp347
I10
aI11
aI12
atp348
a(I-1
S'Megalin and cubilin : multifunctional endocytic receptors'
p349
(lp350
I0
a(lp351
I2
atp352
a(I1
S'Megalin and cubilin are two structurally different endocytic receptors that interact to serve such functions'
p353
(lp354
I0
a(lp355
I2
atp356
a(I1
S'Physical association of beta 2 integrin with GPI - 80 , a novel glycosylphosphatidylinositol - anchored protein with potential for regulating adhesion and migration'
p357
(lp358
I3
aI4
aI5
a(lp359
I7
aI8
aI9
atp360
a(I1
S'To clarify the mechanisms by which GPI - 80 functions on leukocytes , we explored the possibility of its physical association with beta 2 integrin which is important for leukocyte adherence , locomotion , and extravasation'
p361
(lp362
I6
aI7
aI8
a(lp363
I22
aI23
aI24
atp364
a(I1
S'beta 2 integrin , detected by anti - CD18 mAb , was coprecipitated with GPI - 80 from human neutrophil lysates by a mAb to GPI - 80'
p365
(lp366
I0
aI1
aI2
a(lp367
I14
aI15
aI16
atp368
a(I-1
S'beta 2 integrin , detected by anti - CD18 mAb , was coprecipitated with GPI - 80 from human neutrophil lysates by a mAb to GPI - 80'
p369
(lp370
I0
aI1
aI2
a(lp371
I25
aI26
aI27
atp372
a(I-1
S'beta 2 integrin , detected by anti - CD18 mAb , was coprecipitated with GPI - 80 from human neutrophil lysates by a mAb to GPI - 80'
p373
(lp374
I14
aI15
aI16
a(lp375
I25
aI26
aI27
atp376
a(I1
S'In addition , GPI - 80 was immunoprecipitated from human neutrophil lysates by anti - human CD18 mAb'
p377
(lp378
I3
aI4
aI5
a(lp379
I16
atp380
a(I1
S'These results clearly show that GPI - 80 is physically associated with beta 2 integrin in human neutrophils'
p381
(lp382
I5
aI6
aI7
a(lp383
I12
aI13
aI14
atp384
a(I-1
S'GADD45b and GADD45g are cdc2 / cyclinB1 kinase inhibitors with a role in S and G2 / M cell cycle checkpoints induced by genotoxic stress'
p385
(lp386
I0
a(lp387
I2
atp388
a(I1
S'GADD45b and GADD45g are cdc2 / cyclinB1 kinase inhibitors with a role in S and G2 / M cell cycle checkpoints induced by genotoxic stress'
p389
(lp390
I0
a(lp391
I4
atp392
a(I1
S'GADD45b and GADD45g are cdc2 / cyclinB1 kinase inhibitors with a role in S and G2 / M cell cycle checkpoints induced by genotoxic stress'
p393
(lp394
I2
a(lp395
I4
atp396
a(I-1
S'Gadd45a ( Gadd45 ) , Gadd45b ( MyD118 ) , and Gadd45g ( CR6 ) constitute a family of evolutionarily conserved , small , acidic , nuclear proteins , which have been implicated in terminal differentiation , growth suppression , and apoptosis'
p397
(lp398
I0
a(lp399
I2
atp400
a(I-1
S'Gadd45a ( Gadd45 ) , Gadd45b ( MyD118 ) , and Gadd45g ( CR6 ) constitute a family of evolutionarily conserved , small , acidic , nuclear proteins , which have been implicated in terminal differentiation , growth suppression , and apoptosis'
p401
(lp402
I0
a(lp403
I5
atp404
a(I-1
S'Gadd45a ( Gadd45 ) , Gadd45b ( MyD118 ) , and Gadd45g ( CR6 ) constitute a family of evolutionarily conserved , small , acidic , nuclear proteins , which have been implicated in terminal differentiation , growth suppression , and apoptosis'
p405
(lp406
I0
a(lp407
I7
atp408
a(I-1
S'Gadd45a ( Gadd45 ) , Gadd45b ( MyD118 ) , and Gadd45g ( CR6 ) constitute a family of evolutionarily conserved , small , acidic , nuclear proteins , which have been implicated in terminal differentiation , growth suppression , and apoptosis'
p409
(lp410
I0
a(lp411
I11
atp412
a(I-1
S'Gadd45a ( Gadd45 ) , Gadd45b ( MyD118 ) , and Gadd45g ( CR6 ) constitute a family of evolutionarily conserved , small , acidic , nuclear proteins , which have been implicated in terminal differentiation , growth suppression , and apoptosis'
p413
(lp414
I0
a(lp415
I13
atp416
a(I-1
S'Gadd45a ( Gadd45 ) , Gadd45b ( MyD118 ) , and Gadd45g ( CR6 ) constitute a family of evolutionarily conserved , small , acidic , nuclear proteins , which have been implicated in terminal differentiation , growth suppression , and apoptosis'
p417
(lp418
I2
a(lp419
I5
atp420
a(I-1
S'Gadd45a ( Gadd45 ) , Gadd45b ( MyD118 ) , and Gadd45g ( CR6 ) constitute a family of evolutionarily conserved , small , acidic , nuclear proteins , which have been implicated in terminal differentiation , growth suppression , and apoptosis'
p421
(lp422
I2
a(lp423
I7
atp424
a(I-1
S'Gadd45a ( Gadd45 ) , Gadd45b ( MyD118 ) , and Gadd45g ( CR6 ) constitute a family of evolutionarily conserved , small , acidic , nuclear proteins , which have been implicated in terminal differentiation , growth suppression , and apoptosis'
p425
(lp426
I2
a(lp427
I11
atp428
a(I-1
S'Gadd45a ( Gadd45 ) , Gadd45b ( MyD118 ) , and Gadd45g ( CR6 ) constitute a family of evolutionarily conserved , small , acidic , nuclear proteins , which have been implicated in terminal differentiation , growth suppression , and apoptosis'
p429
(lp430
I2
a(lp431
I13
atp432
a(I-1
S'Gadd45a ( Gadd45 ) , Gadd45b ( MyD118 ) , and Gadd45g ( CR6 ) constitute a family of evolutionarily conserved , small , acidic , nuclear proteins , which have been implicated in terminal differentiation , growth suppression , and apoptosis'
p433
(lp434
I5
a(lp435
I7
atp436
a(I-1
S'Gadd45a ( Gadd45 ) , Gadd45b ( MyD118 ) , and Gadd45g ( CR6 ) constitute a family of evolutionarily conserved , small , acidic , nuclear proteins , which have been implicated in terminal differentiation , growth suppression , and apoptosis'
p437
(lp438
I5
a(lp439
I11
atp440
a(I-1
S'Gadd45a ( Gadd45 ) , Gadd45b ( MyD118 ) , and Gadd45g ( CR6 ) constitute a family of evolutionarily conserved , small , acidic , nuclear proteins , which have been implicated in terminal differentiation , growth suppression , and apoptosis'
p441
(lp442
I5
a(lp443
I13
atp444
a(I-1
S'Gadd45a ( Gadd45 ) , Gadd45b ( MyD118 ) , and Gadd45g ( CR6 ) constitute a family of evolutionarily conserved , small , acidic , nuclear proteins , which have been implicated in terminal differentiation , growth suppression , and apoptosis'
p445
(lp446
I7
a(lp447
I11
atp448
a(I-1
S'Gadd45a ( Gadd45 ) , Gadd45b ( MyD118 ) , and Gadd45g ( CR6 ) constitute a family of evolutionarily conserved , small , acidic , nuclear proteins , which have been implicated in terminal differentiation , growth suppression , and apoptosis'
p449
(lp450
I7
a(lp451
I13
atp452
a(I-1
S'Gadd45a ( Gadd45 ) , Gadd45b ( MyD118 ) , and Gadd45g ( CR6 ) constitute a family of evolutionarily conserved , small , acidic , nuclear proteins , which have been implicated in terminal differentiation , growth suppression , and apoptosis'
p453
(lp454
I11
a(lp455
I13
atp456
a(I1
S'Recent evidence has implicated Gadd45a in inhibition of cdc2 / cyclinB1 kinase and in G2 / M cell cycle arrest'
p457
(lp458
I4
a(lp459
I8
atp460
a(I-1
S'Yet , whether Gadd45b and / or Gadd45g function as inhibitors of cdc2 / cyclinB1 kinase and / or play a role in G2 / M cell cycle arrest has not been fully established'
p461
(lp462
I3
a(lp463
I7
atp464
a(I1
S'Yet , whether Gadd45b and / or Gadd45g function as inhibitors of cdc2 / cyclinB1 kinase and / or play a role in G2 / M cell cycle arrest has not been fully established'
p465
(lp466
I3
a(lp467
I12
atp468
a(I1
S'Yet , whether Gadd45b and / or Gadd45g function as inhibitors of cdc2 / cyclinB1 kinase and / or play a role in G2 / M cell cycle arrest has not been fully established'
p469
(lp470
I7
a(lp471
I12
atp472
a(I-1
S'In this work , we show that Gadd45b and Gadd45g specifically interact with the Cdk1 / CyclinB1 complex , but not with other Cdk / Cyclin complexes , in vitro and in vivo'
p473
(lp474
I7
a(lp475
I9
atp476
a(I1
S'In this work , we show that Gadd45b and Gadd45g specifically interact with the Cdk1 / CyclinB1 complex , but not with other Cdk / Cyclin complexes , in vitro and in vivo'
p477
(lp478
I7
a(lp479
I14
atp480
a(I1
S'In this work , we show that Gadd45b and Gadd45g specifically interact with the Cdk1 / CyclinB1 complex , but not with other Cdk / Cyclin complexes , in vitro and in vivo'
p481
(lp482
I9
a(lp483
I14
atp484
a(I-1
S'Data also has been obtained that Gadd45b and Gadd45g , as well as GADD45a , interact with both Cdk1 and cyclinB1 , resulting in inhibition of the kinase activity of the Cdk1 / cyclinB1 complex'
p485
(lp486
I6
a(lp487
I8
atp488
a(I-1
S'Data also has been obtained that Gadd45b and Gadd45g , as well as GADD45a , interact with both Cdk1 and cyclinB1 , resulting in inhibition of the kinase activity of the Cdk1 / cyclinB1 complex'
p489
(lp490
I6
a(lp491
I13
atp492
a(I1
S'Data also has been obtained that Gadd45b and Gadd45g , as well as GADD45a , interact with both Cdk1 and cyclinB1 , resulting in inhibition of the kinase activity of the Cdk1 / cyclinB1 complex'
p493
(lp494
I6
a(lp495
I18
atp496
a(I1
S'Data also has been obtained that Gadd45b and Gadd45g , as well as GADD45a , interact with both Cdk1 and cyclinB1 , resulting in inhibition of the kinase activity of the Cdk1 / cyclinB1 complex'
p497
(lp498
I6
a(lp499
I31
atp500
a(I-1
S'Data also has been obtained that Gadd45b and Gadd45g , as well as GADD45a , interact with both Cdk1 and cyclinB1 , resulting in inhibition of the kinase activity of the Cdk1 / cyclinB1 complex'
p501
(lp502
I8
a(lp503
I13
atp504
a(I1
S'Data also has been obtained that Gadd45b and Gadd45g , as well as GADD45a , interact with both Cdk1 and cyclinB1 , resulting in inhibition of the kinase activity of the Cdk1 / cyclinB1 complex'
p505
(lp506
I8
a(lp507
I18
atp508
a(I1
S'Data also has been obtained that Gadd45b and Gadd45g , as well as GADD45a , interact with both Cdk1 and cyclinB1 , resulting in inhibition of the kinase activity of the Cdk1 / cyclinB1 complex'
p509
(lp510
I8
a(lp511
I31
atp512
a(I1
S'Data also has been obtained that Gadd45b and Gadd45g , as well as GADD45a , interact with both Cdk1 and cyclinB1 , resulting in inhibition of the kinase activity of the Cdk1 / cyclinB1 complex'
p513
(lp514
I13
a(lp515
I18
atp516
a(I1
S'Data also has been obtained that Gadd45b and Gadd45g , as well as GADD45a , interact with both Cdk1 and cyclinB1 , resulting in inhibition of the kinase activity of the Cdk1 / cyclinB1 complex'
p517
(lp518
I13
a(lp519
I31
atp520
a(I-1
S'Data also has been obtained that Gadd45b and Gadd45g , as well as GADD45a , interact with both Cdk1 and cyclinB1 , resulting in inhibition of the kinase activity of the Cdk1 / cyclinB1 complex'
p521
(lp522
I18
a(lp523
I31
atp524
a(I1
S'Inhibition of Cdk1 / cyclinB1 kinase activity by Gadd45b and Gadd45a was found to involve disruption of the complex , whereas Gadd45g did not disrupt the complex'
p525
(lp526
I2
a(lp527
I8
atp528
a(I1
S'Inhibition of Cdk1 / cyclinB1 kinase activity by Gadd45b and Gadd45a was found to involve disruption of the complex , whereas Gadd45g did not disrupt the complex'
p529
(lp530
I2
a(lp531
I10
atp532
a(I-1
S'Inhibition of Cdk1 / cyclinB1 kinase activity by Gadd45b and Gadd45a was found to involve disruption of the complex , whereas Gadd45g did not disrupt the complex'
p533
(lp534
I2
a(lp535
I21
atp536
a(I-1
S'Inhibition of Cdk1 / cyclinB1 kinase activity by Gadd45b and Gadd45a was found to involve disruption of the complex , whereas Gadd45g did not disrupt the complex'
p537
(lp538
I8
a(lp539
I10
atp540
a(I-1
S'Inhibition of Cdk1 / cyclinB1 kinase activity by Gadd45b and Gadd45a was found to involve disruption of the complex , whereas Gadd45g did not disrupt the complex'
p541
(lp542
I8
a(lp543
I21
atp544
a(I-1
S'Inhibition of Cdk1 / cyclinB1 kinase activity by Gadd45b and Gadd45a was found to involve disruption of the complex , whereas Gadd45g did not disrupt the complex'
p545
(lp546
I10
a(lp547
I21
atp548
a(I-1
S'DGKdelta ( type II isozyme ) contains a pleckstrin homology domain at the N terminus and a sterile alpha motif domain at the C terminus'
p549
(lp550
I0
a(lp551
I8
atp552
a(I-1
S'The transmembrane receptor protein tyrosine phosphatase DEP1 interacts with p120 ( ctn )'
p553
(lp554
I2
aI3
aI4
aI5
a(lp555
I6
atp556
a(I1
S'The transmembrane receptor protein tyrosine phosphatase DEP1 interacts with p120 ( ctn )'
p557
(lp558
I2
aI3
aI4
aI5
a(lp559
I9
aI10
aI11
aI12
atp560
a(I1
S'The transmembrane receptor protein tyrosine phosphatase DEP1 interacts with p120 ( ctn )'
p561
(lp562
I6
a(lp563
I9
aI10
aI11
aI12
atp564
a(I-1
S'The receptor - like protein tyrosine phosphatase DEP1 , also known as CD148 , is expressed predominantly in epithelial cells , in a variety of tumor cell lines , and in lymphocytes'
p565
(lp566
I1
aI2
aI3
aI4
aI5
aI6
a(lp567
I7
atp568
a(I-1
S'The receptor - like protein tyrosine phosphatase DEP1 , also known as CD148 , is expressed predominantly in epithelial cells , in a variety of tumor cell lines , and in lymphocytes'
p569
(lp570
I1
aI2
aI3
aI4
aI5
aI6
a(lp571
I12
atp572
a(I-1
S'The receptor - like protein tyrosine phosphatase DEP1 , also known as CD148 , is expressed predominantly in epithelial cells , in a variety of tumor cell lines , and in lymphocytes'
p573
(lp574
I7
a(lp575
I12
atp576
a(I1
S'DEP1 also interacted with other members of the catenin gene family including beta - catenin and gamma - catenin'
p577
(lp578
I0
a(lp579
I12
aI13
aI14
atp580
a(I-1
S'The interaction with p120 ( ctn ) is likely to be direct , as the interaction occurs in K562 cells lacking functional adherens junctions and E - cadherin expression'
p581
(lp582
I3
aI4
aI5
aI6
a(lp583
I25
aI26
aI27
atp584
a(I-1
S'Catalytic domains of the tyrosine phosphatases PTP - PEST , CD45 , and PTPbeta did not interact with proteins of the catenin family to detectable levels , suggesting that the interaction of DEP1 with these proteins is specific'
p585
(lp586
I6
aI7
aI8
a(lp587
I10
atp588
a(I-1
S'Catalytic domains of the tyrosine phosphatases PTP - PEST , CD45 , and PTPbeta did not interact with proteins of the catenin family to detectable levels , suggesting that the interaction of DEP1 with these proteins is specific'
p589
(lp590
I6
aI7
aI8
a(lp591
I32
atp592
a(I-1
S'Catalytic domains of the tyrosine phosphatases PTP - PEST , CD45 , and PTPbeta did not interact with proteins of the catenin family to detectable levels , suggesting that the interaction of DEP1 with these proteins is specific'
p593
(lp594
I10
a(lp595
I32
atp596
a(I-1
S"p300 / cAMP - response - element - binding - protein ( ' CREB ' ) - binding protein ( CBP ) modulates co - operation between myocyte enhancer factor 2A ( MEF2A ) and thyroid hormone receptor - retinoid X receptor"
p597
(lp598
I0
a(lp599
I2
aI3
aI4
aI5
aI6
aI7
aI8
aI9
aI10
atp600
a(I-1
S"p300 / cAMP - response - element - binding - protein ( ' CREB ' ) - binding protein ( CBP ) modulates co - operation between myocyte enhancer factor 2A ( MEF2A ) and thyroid hormone receptor - retinoid X receptor"
p601
(lp602
I0
a(lp603
I13
atp604
a(I1
S"p300 / cAMP - response - element - binding - protein ( ' CREB ' ) - binding protein ( CBP ) modulates co - operation between myocyte enhancer factor 2A ( MEF2A ) and thyroid hormone receptor - retinoid X receptor"
p605
(lp606
I0
a(lp607
I32
atp608
a(I-1
S"p300 / cAMP - response - element - binding - protein ( ' CREB ' ) - binding protein ( CBP ) modulates co - operation between myocyte enhancer factor 2A ( MEF2A ) and thyroid hormone receptor - retinoid X receptor"
p609
(lp610
I2
aI3
aI4
aI5
aI6
aI7
aI8
aI9
aI10
a(lp611
I13
atp612
a(I1
S"p300 / cAMP - response - element - binding - protein ( ' CREB ' ) - binding protein ( CBP ) modulates co - operation between myocyte enhancer factor 2A ( MEF2A ) and thyroid hormone receptor - retinoid X receptor"
p613
(lp614
I2
aI3
aI4
aI5
aI6
aI7
aI8
aI9
aI10
a(lp615
I32
atp616
a(I1
S"p300 / cAMP - response - element - binding - protein ( ' CREB ' ) - binding protein ( CBP ) modulates co - operation between myocyte enhancer factor 2A ( MEF2A ) and thyroid hormone receptor - retinoid X receptor"
p617
(lp618
I13
a(lp619
I32
atp620
a(I-1
S"p300 / cAMP - response - element - binding - protein ( ' CREB ' ) - binding protein ( CBP ) interacting with transcription factors is able to increase their activity on target gene promoters"
p621
(lp622
I0
a(lp623
I2
aI3
aI4
aI5
aI6
aI7
aI8
aI9
aI10
atp624
a(I-1
S"p300 / cAMP - response - element - binding - protein ( ' CREB ' ) - binding protein ( CBP ) interacting with transcription factors is able to increase their activity on target gene promoters"
p625
(lp626
I0
a(lp627
I13
atp628
a(I-1
S"p300 / cAMP - response - element - binding - protein ( ' CREB ' ) - binding protein ( CBP ) interacting with transcription factors is able to increase their activity on target gene promoters"
p629
(lp630
I2
aI3
aI4
aI5
aI6
aI7
aI8
aI9
aI10
a(lp631
I13
atp632
a(I1
S'Our findings showed that the same C - terminal portion of p300 binds the N - terminal domains of both TR and MEF2A , and our in vivo studies demonstrated that TR , MEF2A and p300 form a ternary complex'
p633
(lp634
I11
a(lp635
I22
atp636
a(I-1
S'Our findings showed that the same C - terminal portion of p300 binds the N - terminal domains of both TR and MEF2A , and our in vivo studies demonstrated that TR , MEF2A and p300 form a ternary complex'
p637
(lp638
I11
a(lp639
I33
atp640
a(I-1
S'Our findings showed that the same C - terminal portion of p300 binds the N - terminal domains of both TR and MEF2A , and our in vivo studies demonstrated that TR , MEF2A and p300 form a ternary complex'
p641
(lp642
I11
a(lp643
I35
atp644
a(I-1
S'Our findings showed that the same C - terminal portion of p300 binds the N - terminal domains of both TR and MEF2A , and our in vivo studies demonstrated that TR , MEF2A and p300 form a ternary complex'
p645
(lp646
I22
a(lp647
I33
atp648
a(I-1
S'Our findings showed that the same C - terminal portion of p300 binds the N - terminal domains of both TR and MEF2A , and our in vivo studies demonstrated that TR , MEF2A and p300 form a ternary complex'
p649
(lp650
I22
a(lp651
I35
atp652
a(I1
S'Our findings showed that the same C - terminal portion of p300 binds the N - terminal domains of both TR and MEF2A , and our in vivo studies demonstrated that TR , MEF2A and p300 form a ternary complex'
p653
(lp654
I33
a(lp655
I35
atp656
a(I1
S'The human Imp3 and Imp4 proteins form a ternary complex with hMpp10 , which only interacts with the U3 snoRNA in 60 - 80S ribonucleoprotein complexes'
p657
(lp658
I2
a(lp659
I4
atp660
a(I1
S'The human Imp3 and Imp4 proteins form a ternary complex with hMpp10 , which only interacts with the U3 snoRNA in 60 - 80S ribonucleoprotein complexes'
p661
(lp662
I2
a(lp663
I19
atp664
a(I1
S'The human Imp3 and Imp4 proteins form a ternary complex with hMpp10 , which only interacts with the U3 snoRNA in 60 - 80S ribonucleoprotein complexes'
p665
(lp666
I4
a(lp667
I19
atp668
a(I-1
S'We have cloned cDNAs encoding the human and mouse homologs of the yeast U3 snoRNP - associated proteins Imp3 and Imp4'
p669
(lp670
I18
a(lp671
I20
atp672
a(I-1
S'The results of complementation experiments show that , in contrast to mouse Imp4 , mouse Imp3 can partially alleviate the growth defect of the corresponding yeast null strain , indicating that the role of Imp3 in pre - rRNA processing is evolutionarily conserved'
p673
(lp674
I12
a(lp675
I15
atp676
a(I-1
S'The results of complementation experiments show that , in contrast to mouse Imp4 , mouse Imp3 can partially alleviate the growth defect of the corresponding yeast null strain , indicating that the role of Imp3 in pre - rRNA processing is evolutionarily conserved'
p677
(lp678
I12
a(lp679
I34
atp680
a(I-1
S'The results of complementation experiments show that , in contrast to mouse Imp4 , mouse Imp3 can partially alleviate the growth defect of the corresponding yeast null strain , indicating that the role of Imp3 in pre - rRNA processing is evolutionarily conserved'
p681
(lp682
I15
a(lp683
I34
atp684
a(I-1
S'The results of density gradient centrifugation experiments show that , in contrast to hU3 - 55K , the human Imp3 and Imp4 proteins predominantly interact with the U3 snoRNA in 60 - 80S ribonucleoprotein complexes'
p685
(lp686
I19
a(lp687
I21
atp688
a(I1
S'The results of density gradient centrifugation experiments show that , in contrast to hU3 - 55K , the human Imp3 and Imp4 proteins predominantly interact with the U3 snoRNA in 60 - 80S ribonucleoprotein complexes'
p689
(lp690
I19
a(lp691
I28
atp692
a(I1
S'The results of density gradient centrifugation experiments show that , in contrast to hU3 - 55K , the human Imp3 and Imp4 proteins predominantly interact with the U3 snoRNA in 60 - 80S ribonucleoprotein complexes'
p693
(lp694
I21
a(lp695
I28
atp696
a(I1
S'In the present study , we observed evidence of cross - talk between the cannabinoid receptor CB1 and the orexin 1 receptor ( OX1R ) using a heterologous system'
p697
(lp698
I16
a(lp699
I19
aI20
aI21
atp700
a(I1
S'In the present study , we observed evidence of cross - talk between the cannabinoid receptor CB1 and the orexin 1 receptor ( OX1R ) using a heterologous system'
p701
(lp702
I16
a(lp703
I23
atp704
a(I-1
S'In the present study , we observed evidence of cross - talk between the cannabinoid receptor CB1 and the orexin 1 receptor ( OX1R ) using a heterologous system'
p705
(lp706
I19
aI20
aI21
a(lp707
I23
atp708
a(I-1
S'In contrast to OX1R , the potency of direct activation of CB1 was not affected by co - expression with OX1R'
p709
(lp710
I3
a(lp711
I11
atp712
a(I-1
S'In contrast to OX1R , the potency of direct activation of CB1 was not affected by co - expression with OX1R'
p713
(lp714
I3
a(lp715
I20
atp716
a(I-1
S'In contrast to OX1R , the potency of direct activation of CB1 was not affected by co - expression with OX1R'
p717
(lp718
I11
a(lp719
I20
atp720
a(I-1
S'In addition , electron microscopy experiments revealed that CB1 and OX1R are closely apposed at the plasma membrane level ; they are close enough to form hetero - oligomers'
p721
(lp722
I8
a(lp723
I10
atp724
a(I-1
S'GC - GAP , a Rho family GTPase - activating protein that interacts with signaling adapters Gab1 and Gab2'
p725
(lp726
I0
aI1
aI2
a(lp727
I7
aI8
aI9
aI10
atp728
a(I1
S'GC - GAP , a Rho family GTPase - activating protein that interacts with signaling adapters Gab1 and Gab2'
p729
(lp730
I0
aI1
aI2
a(lp731
I16
atp732
a(I1
S'GC - GAP , a Rho family GTPase - activating protein that interacts with signaling adapters Gab1 and Gab2'
p733
(lp734
I0
aI1
aI2
a(lp735
I18
atp736
a(I1
S'GC - GAP , a Rho family GTPase - activating protein that interacts with signaling adapters Gab1 and Gab2'
p737
(lp738
I7
aI8
aI9
aI10
a(lp739
I16
atp740
a(I1
S'GC - GAP , a Rho family GTPase - activating protein that interacts with signaling adapters Gab1 and Gab2'
p741
(lp742
I7
aI8
aI9
aI10
a(lp743
I18
atp744
a(I-1
S'GC - GAP , a Rho family GTPase - activating protein that interacts with signaling adapters Gab1 and Gab2'
p745
(lp746
I16
a(lp747
I18
atp748
a(I-1
S'Gab1 and Gab2 are scaffolding proteins acting downstream of cell surface receptors and interact with a variety of cytoplasmic signaling proteins such as Grb2 , Shp - 2 , phosphatidylinositol 3 - kinase , Shc , and Crk'
p749
(lp750
I0
a(lp751
I2
atp752
a(I1
S'Gab1 and Gab2 are scaffolding proteins acting downstream of cell surface receptors and interact with a variety of cytoplasmic signaling proteins such as Grb2 , Shp - 2 , phosphatidylinositol 3 - kinase , Shc , and Crk'
p753
(lp754
I0
a(lp755
I23
atp756
a(I1
S'Gab1 and Gab2 are scaffolding proteins acting downstream of cell surface receptors and interact with a variety of cytoplasmic signaling proteins such as Grb2 , Shp - 2 , phosphatidylinositol 3 - kinase , Shc , and Crk'
p757
(lp758
I0
a(lp759
I25
aI26
aI27
atp760
a(I1
S'Gab1 and Gab2 are scaffolding proteins acting downstream of cell surface receptors and interact with a variety of cytoplasmic signaling proteins such as Grb2 , Shp - 2 , phosphatidylinositol 3 - kinase , Shc , and Crk'
p761
(lp762
I0
a(lp763
I29
aI30
aI31
aI32
atp764
a(I1
S'Gab1 and Gab2 are scaffolding proteins acting downstream of cell surface receptors and interact with a variety of cytoplasmic signaling proteins such as Grb2 , Shp - 2 , phosphatidylinositol 3 - kinase , Shc , and Crk'
p765
(lp766
I2
a(lp767
I23
atp768
a(I1
S'Gab1 and Gab2 are scaffolding proteins acting downstream of cell surface receptors and interact with a variety of cytoplasmic signaling proteins such as Grb2 , Shp - 2 , phosphatidylinositol 3 - kinase , Shc , and Crk'
p769
(lp770
I2
a(lp771
I25
aI26
aI27
atp772
a(I1
S'Gab1 and Gab2 are scaffolding proteins acting downstream of cell surface receptors and interact with a variety of cytoplasmic signaling proteins such as Grb2 , Shp - 2 , phosphatidylinositol 3 - kinase , Shc , and Crk'
p773
(lp774
I2
a(lp775
I29
aI30
aI31
aI32
atp776
a(I-1
S'Gab1 and Gab2 are scaffolding proteins acting downstream of cell surface receptors and interact with a variety of cytoplasmic signaling proteins such as Grb2 , Shp - 2 , phosphatidylinositol 3 - kinase , Shc , and Crk'
p777
(lp778
I23
a(lp779
I25
aI26
aI27
atp780
a(I-1
S'Gab1 and Gab2 are scaffolding proteins acting downstream of cell surface receptors and interact with a variety of cytoplasmic signaling proteins such as Grb2 , Shp - 2 , phosphatidylinositol 3 - kinase , Shc , and Crk'
p781
(lp782
I23
a(lp783
I29
aI30
aI31
aI32
atp784
a(I-1
S'Gab1 and Gab2 are scaffolding proteins acting downstream of cell surface receptors and interact with a variety of cytoplasmic signaling proteins such as Grb2 , Shp - 2 , phosphatidylinositol 3 - kinase , Shc , and Crk'
p785
(lp786
I25
aI26
aI27
a(lp787
I29
aI30
aI31
aI32
atp788
a(I1
S'In addition , GC - GAP contains several classic proline - rich motifs , and it interacts with the first SH3 domain of Crk and full - length Nck in vitro'
p789
(lp790
I3
aI4
aI5
a(lp791
I28
atp792
a(I-1
S'We propose that Gab1 and Gab2 in cooperation with other adapter molecules might regulate the cellular localization of GC - GAP under specific stimuli , acting to regulate precisely Rac and Cdc42 activities'
p793
(lp794
I3
a(lp795
I5
atp796
a(I1
S'We propose that Gab1 and Gab2 in cooperation with other adapter molecules might regulate the cellular localization of GC - GAP under specific stimuli , acting to regulate precisely Rac and Cdc42 activities'
p797
(lp798
I3
a(lp799
I18
aI19
aI20
atp800
a(I1
S'We propose that Gab1 and Gab2 in cooperation with other adapter molecules might regulate the cellular localization of GC - GAP under specific stimuli , acting to regulate precisely Rac and Cdc42 activities'
p801
(lp802
I3
a(lp803
I31
atp804
a(I1
S'We propose that Gab1 and Gab2 in cooperation with other adapter molecules might regulate the cellular localization of GC - GAP under specific stimuli , acting to regulate precisely Rac and Cdc42 activities'
p805
(lp806
I5
a(lp807
I18
aI19
aI20
atp808
a(I1
S'We propose that Gab1 and Gab2 in cooperation with other adapter molecules might regulate the cellular localization of GC - GAP under specific stimuli , acting to regulate precisely Rac and Cdc42 activities'
p809
(lp810
I5
a(lp811
I31
atp812
a(I-1
S'We propose that Gab1 and Gab2 in cooperation with other adapter molecules might regulate the cellular localization of GC - GAP under specific stimuli , acting to regulate precisely Rac and Cdc42 activities'
p813
(lp814
I18
aI19
aI20
a(lp815
I31
atp816
a(I-1
S'This work led to identification of a novel GTPase - activating protein ( GAP ) for Rho family GTPases'
p817
(lp818
I8
aI9
aI10
aI11
a(lp819
I13
atp820
a(I-1
S'The GAP domain shows high similarity to the recently cloned CdGAP and displays activity toward RhoA , Rac1 , and Cdc42 in vitro'
p821
(lp822
I10
a(lp823
I17
atp824
a(I-1
S'The GAP domain shows high similarity to the recently cloned CdGAP and displays activity toward RhoA , Rac1 , and Cdc42 in vitro'
p825
(lp826
I10
a(lp827
I20
atp828
a(I-1
S'The GAP domain shows high similarity to the recently cloned CdGAP and displays activity toward RhoA , Rac1 , and Cdc42 in vitro'
p829
(lp830
I17
a(lp831
I20
atp832
a(I1
S'The protein was named GC - GAP for its ability to interact with GAB proteins and its activity toward Rac and Cdc42'
p833
(lp834
I4
aI5
aI6
a(lp835
I13
atp836
a(I1
S'The protein was named GC - GAP for its ability to interact with GAB proteins and its activity toward Rac and Cdc42'
p837
(lp838
I4
aI5
aI6
a(lp839
I21
atp840
a(I-1
S'The protein was named GC - GAP for its ability to interact with GAB proteins and its activity toward Rac and Cdc42'
p841
(lp842
I13
a(lp843
I21
atp844
a(I1
S'Expression of GC - GAP in 293T cells led to a reduction in active Rac1 and Cdc42 levels but not RhoA'
p845
(lp846
I2
aI3
aI4
a(lp847
I14
atp848
a(I1
S'Expression of GC - GAP in 293T cells led to a reduction in active Rac1 and Cdc42 levels but not RhoA'
p849
(lp850
I2
aI3
aI4
a(lp851
I16
atp852
a(I-1
S'Expression of GC - GAP in 293T cells led to a reduction in active Rac1 and Cdc42 levels but not RhoA'
p853
(lp854
I14
a(lp855
I16
atp856
a(I1
S'A role for Plk1 phosphorylation of NudC in cytokinesis'
p857
(lp858
I3
a(lp859
I6
atp860
a(I1
S'Here , we characterize the interaction between Plk1 and NudC , show that Plk1 phosphorylates NudC at conserved S274 and S326 residues in vitro , and present evidence that NudC is also a substrate for Plk1 in vivo'
p861
(lp862
I7
a(lp863
I9
atp864
a(I-1
S'Here , we characterize the interaction between Plk1 and NudC , show that Plk1 phosphorylates NudC at conserved S274 and S326 residues in vitro , and present evidence that NudC is also a substrate for Plk1 in vivo'
p865
(lp866
I7
a(lp867
I13
atp868
a(I-1
S'Here , we characterize the interaction between Plk1 and NudC , show that Plk1 phosphorylates NudC at conserved S274 and S326 residues in vitro , and present evidence that NudC is also a substrate for Plk1 in vivo'
p869
(lp870
I7
a(lp871
I15
atp872
a(I-1
S'Here , we characterize the interaction between Plk1 and NudC , show that Plk1 phosphorylates NudC at conserved S274 and S326 residues in vitro , and present evidence that NudC is also a substrate for Plk1 in vivo'
p873
(lp874
I7
a(lp875
I29
atp876
a(I-1
S'Here , we characterize the interaction between Plk1 and NudC , show that Plk1 phosphorylates NudC at conserved S274 and S326 residues in vitro , and present evidence that NudC is also a substrate for Plk1 in vivo'
p877
(lp878
I7
a(lp879
I35
atp880
a(I-1
S'Here , we characterize the interaction between Plk1 and NudC , show that Plk1 phosphorylates NudC at conserved S274 and S326 residues in vitro , and present evidence that NudC is also a substrate for Plk1 in vivo'
p881
(lp882
I9
a(lp883
I13
atp884
a(I-1
S'Here , we characterize the interaction between Plk1 and NudC , show that Plk1 phosphorylates NudC at conserved S274 and S326 residues in vitro , and present evidence that NudC is also a substrate for Plk1 in vivo'
p885
(lp886
I9
a(lp887
I15
atp888
a(I-1
S'Here , we characterize the interaction between Plk1 and NudC , show that Plk1 phosphorylates NudC at conserved S274 and S326 residues in vitro , and present evidence that NudC is also a substrate for Plk1 in vivo'
p889
(lp890
I9
a(lp891
I29
atp892
a(I-1
S'Here , we characterize the interaction between Plk1 and NudC , show that Plk1 phosphorylates NudC at conserved S274 and S326 residues in vitro , and present evidence that NudC is also a substrate for Plk1 in vivo'
p893
(lp894
I9
a(lp895
I35
atp896
a(I1
S'Here , we characterize the interaction between Plk1 and NudC , show that Plk1 phosphorylates NudC at conserved S274 and S326 residues in vitro , and present evidence that NudC is also a substrate for Plk1 in vivo'
p897
(lp898
I13
a(lp899
I15
atp900
a(I-1
S'Here , we characterize the interaction between Plk1 and NudC , show that Plk1 phosphorylates NudC at conserved S274 and S326 residues in vitro , and present evidence that NudC is also a substrate for Plk1 in vivo'
p901
(lp902
I13
a(lp903
I29
atp904
a(I-1
S'Here , we characterize the interaction between Plk1 and NudC , show that Plk1 phosphorylates NudC at conserved S274 and S326 residues in vitro , and present evidence that NudC is also a substrate for Plk1 in vivo'
p905
(lp906
I13
a(lp907
I35
atp908
a(I-1
S'Here , we characterize the interaction between Plk1 and NudC , show that Plk1 phosphorylates NudC at conserved S274 and S326 residues in vitro , and present evidence that NudC is also a substrate for Plk1 in vivo'
p909
(lp910
I15
a(lp911
I29
atp912
a(I-1
S'Here , we characterize the interaction between Plk1 and NudC , show that Plk1 phosphorylates NudC at conserved S274 and S326 residues in vitro , and present evidence that NudC is also a substrate for Plk1 in vivo'
p913
(lp914
I15
a(lp915
I35
atp916
a(I1
S'Here , we characterize the interaction between Plk1 and NudC , show that Plk1 phosphorylates NudC at conserved S274 and S326 residues in vitro , and present evidence that NudC is also a substrate for Plk1 in vivo'
p917
(lp918
I29
a(lp919
I35
atp920
a(I-1
S'Downregulation of NudC by RNA interference results in multiple mitotic defects , including multinucleation and cells arrested at the midbody stage , which are rescued by ectopic expression of wild - type NudC , but not by NudC with mutations in the Plk1 phosphorylation sites'
p921
(lp922
I2
a(lp923
I32
atp924
a(I-1
S'Downregulation of NudC by RNA interference results in multiple mitotic defects , including multinucleation and cells arrested at the midbody stage , which are rescued by ectopic expression of wild - type NudC , but not by NudC with mutations in the Plk1 phosphorylation sites'
p925
(lp926
I2
a(lp927
I37
atp928
a(I-1
S'Downregulation of NudC by RNA interference results in multiple mitotic defects , including multinucleation and cells arrested at the midbody stage , which are rescued by ectopic expression of wild - type NudC , but not by NudC with mutations in the Plk1 phosphorylation sites'
p929
(lp930
I2
a(lp931
I42
atp932
a(I-1
S'Downregulation of NudC by RNA interference results in multiple mitotic defects , including multinucleation and cells arrested at the midbody stage , which are rescued by ectopic expression of wild - type NudC , but not by NudC with mutations in the Plk1 phosphorylation sites'
p933
(lp934
I32
a(lp935
I37
atp936
a(I-1
S'Downregulation of NudC by RNA interference results in multiple mitotic defects , including multinucleation and cells arrested at the midbody stage , which are rescued by ectopic expression of wild - type NudC , but not by NudC with mutations in the Plk1 phosphorylation sites'
p937
(lp938
I32
a(lp939
I42
atp940
a(I-1
S'Downregulation of NudC by RNA interference results in multiple mitotic defects , including multinucleation and cells arrested at the midbody stage , which are rescued by ectopic expression of wild - type NudC , but not by NudC with mutations in the Plk1 phosphorylation sites'
p941
(lp942
I37
a(lp943
I42
atp944
a(I1
S'These results suggest that Plk1 phosphorylation of NudC may influence cytokinesis'
p945
(lp946
I4
a(lp947
I7
atp948
a(I1
S'Specific interaction of Egr1 and c / EBPbeta leads to the transcriptional activation of the human low density lipoprotein receptor gene'
p949
(lp950
I3
a(lp951
I16
aI17
aI18
aI19
atp952
a(I-1
S'The sterol - independent regulatory element ( SIRE ) of the LDL receptor ( LDLR ) promoter mediates oncostatin M ( OM ) - induced transcription of the LDLR gene through a cholesterol - independent pathway'
p953
(lp954
I11
aI12
a(lp955
I14
atp956
a(I1
S'The sterol - independent regulatory element ( SIRE ) of the LDL receptor ( LDLR ) promoter mediates oncostatin M ( OM ) - induced transcription of the LDLR gene through a cholesterol - independent pathway'
p957
(lp958
I11
aI12
a(lp959
I18
aI19
atp960
a(I-1
S'The sterol - independent regulatory element ( SIRE ) of the LDL receptor ( LDLR ) promoter mediates oncostatin M ( OM ) - induced transcription of the LDLR gene through a cholesterol - independent pathway'
p961
(lp962
I11
aI12
a(lp963
I28
atp964
a(I1
S'The sterol - independent regulatory element ( SIRE ) of the LDL receptor ( LDLR ) promoter mediates oncostatin M ( OM ) - induced transcription of the LDLR gene through a cholesterol - independent pathway'
p965
(lp966
I14
a(lp967
I18
aI19
atp968
a(I-1
S'The sterol - independent regulatory element ( SIRE ) of the LDL receptor ( LDLR ) promoter mediates oncostatin M ( OM ) - induced transcription of the LDLR gene through a cholesterol - independent pathway'
p969
(lp970
I14
a(lp971
I28
atp972
a(I1
S'The sterol - independent regulatory element ( SIRE ) of the LDL receptor ( LDLR ) promoter mediates oncostatin M ( OM ) - induced transcription of the LDLR gene through a cholesterol - independent pathway'
p973
(lp974
I18
aI19
a(lp975
I28
atp976
a(I1
S'TR2 orphan receptor functions as negative modulator for androgen receptor in prostate cancer cells PC - 3'
p977
(lp978
I0
a(lp979
I8
aI9
atp980
a(I-1
S'TR2 orphan receptor functions as negative modulator for androgen receptor in prostate cancer cells PC - 3'
p981
(lp982
I0
a(lp983
I14
aI15
aI16
atp984
a(I-1
S'TR2 orphan receptor functions as negative modulator for androgen receptor in prostate cancer cells PC - 3'
p985
(lp986
I8
aI9
a(lp987
I14
aI15
aI16
atp988
a(I-1
S'BACKGROUND : Both androgen receptor ( AR ) and orphan receptor TR2 ( TR2 ) belong to the steroid nuclear receptor superfamily and are expressed in prostate cancer tissue and cell lines'
p989
(lp990
I3
aI4
a(lp991
I11
atp992
a(I-1
S'BACKGROUND : Both androgen receptor ( AR ) and orphan receptor TR2 ( TR2 ) belong to the steroid nuclear receptor superfamily and are expressed in prostate cancer tissue and cell lines'
p993
(lp994
I3
aI4
a(lp995
I13
atp996
a(I-1
S'BACKGROUND : Both androgen receptor ( AR ) and orphan receptor TR2 ( TR2 ) belong to the steroid nuclear receptor superfamily and are expressed in prostate cancer tissue and cell lines'
p997
(lp998
I11
a(lp999
I13
atp1000
a(I-1
S'The interaction between AR and TR2 was assessed by glutathione - S - transferase ( GST ) pull - down assay and mammalian two - hybrid system assay'
p1001
(lp1002
I5
a(lp1003
I9
aI10
aI11
aI12
aI13
atp1004
a(I-1
S'The interaction between AR and TR2 was assessed by glutathione - S - transferase ( GST ) pull - down assay and mammalian two - hybrid system assay'
p1005
(lp1006
I5
a(lp1007
I15
atp1008
a(I-1
S'The interaction between AR and TR2 was assessed by glutathione - S - transferase ( GST ) pull - down assay and mammalian two - hybrid system assay'
p1009
(lp1010
I9
aI10
aI11
aI12
aI13
a(lp1011
I15
atp1012
a(I1
S'The protein pVHL functions in a multi - subunit E3 ubiquitin ligase that targets the hypoxia - inducible transcription factor Hif1 alpha for proteasomal degradation during normoxia'
p1013
(lp1014
I2
a(lp1015
I20
aI21
atp1016
a(I1
S'We establish that pVHL binds to Tat - binding protein - 1 ( TBP - 1 ) , a component of the 19S regulatory complex of the proteasome'
p1017
(lp1018
I3
a(lp1019
I6
aI7
aI8
aI9
aI10
aI11
atp1020
a(I1
S'We establish that pVHL binds to Tat - binding protein - 1 ( TBP - 1 ) , a component of the 19S regulatory complex of the proteasome'
p1021
(lp1022
I3
a(lp1023
I13
aI14
aI15
atp1024
a(I-1
S'We establish that pVHL binds to Tat - binding protein - 1 ( TBP - 1 ) , a component of the 19S regulatory complex of the proteasome'
p1025
(lp1026
I6
aI7
aI8
aI9
aI10
aI11
a(lp1027
I13
aI14
aI15
atp1028
a(I1
S'TBP - 1 associates with the beta - domain of pVHL and complexes with pVHL and Hif1 alpha in vivo'
p1029
(lp1030
I0
aI1
aI2
a(lp1031
I10
atp1032
a(I1
S'TBP - 1 associates with the beta - domain of pVHL and complexes with pVHL and Hif1 alpha in vivo'
p1033
(lp1034
I0
aI1
aI2
a(lp1035
I14
atp1036
a(I1
S'TBP - 1 associates with the beta - domain of pVHL and complexes with pVHL and Hif1 alpha in vivo'
p1037
(lp1038
I0
aI1
aI2
a(lp1039
I16
aI17
atp1040
a(I-1
S'TBP - 1 associates with the beta - domain of pVHL and complexes with pVHL and Hif1 alpha in vivo'
p1041
(lp1042
I10
a(lp1043
I14
atp1044
a(I-1
S'TBP - 1 associates with the beta - domain of pVHL and complexes with pVHL and Hif1 alpha in vivo'
p1045
(lp1046
I10
a(lp1047
I16
aI17
atp1048
a(I-1
S'TBP - 1 associates with the beta - domain of pVHL and complexes with pVHL and Hif1 alpha in vivo'
p1049
(lp1050
I14
a(lp1051
I16
aI17
atp1052
a(I1
S'Overexpression of TBP - 1 promotes degradation of Hif1 alpha in a pVHL - dependent manner that requires the ATPase domain of TBP - 1'
p1053
(lp1054
I2
aI3
aI4
a(lp1055
I8
aI9
atp1056
a(I-1
S'Overexpression of TBP - 1 promotes degradation of Hif1 alpha in a pVHL - dependent manner that requires the ATPase domain of TBP - 1'
p1057
(lp1058
I2
aI3
aI4
a(lp1059
I22
aI23
aI24
atp1060
a(I1
S'Overexpression of TBP - 1 promotes degradation of Hif1 alpha in a pVHL - dependent manner that requires the ATPase domain of TBP - 1'
p1061
(lp1062
I8
aI9
a(lp1063
I22
aI23
aI24
atp1064
a(I1
S'Blockade of TBP - 1 expression by small interfering RNA ( siRNA ) causes prolonged degradation kinetics of Hif1 alpha'
p1065
(lp1066
I2
aI3
aI4
a(lp1067
I18
aI19
atp1068
a(I-1
S'Several distinct mutations in exon 2 of VHL disrupt binding of pVHL to TBP - 1'
p1069
(lp1070
I7
a(lp1071
I11
atp1072
a(I1
S'Several distinct mutations in exon 2 of VHL disrupt binding of pVHL to TBP - 1'
p1073
(lp1074
I7
a(lp1075
I13
aI14
aI15
atp1076
a(I1
S'Several distinct mutations in exon 2 of VHL disrupt binding of pVHL to TBP - 1'
p1077
(lp1078
I11
a(lp1079
I13
aI14
aI15
atp1080
a(I1
S'A pVHL mutant containing a P154L substitution coimmunoprecipitates with Hif1 alpha , but not TBP - 1 , and does not promote degradation of Hif1 alpha'
p1081
(lp1082
I1
a(lp1083
I9
aI10
atp1084
a(I-1
S'A pVHL mutant containing a P154L substitution coimmunoprecipitates with Hif1 alpha , but not TBP - 1 , and does not promote degradation of Hif1 alpha'
p1085
(lp1086
I1
a(lp1087
I14
aI15
aI16
atp1088
a(I-1
S'A pVHL mutant containing a P154L substitution coimmunoprecipitates with Hif1 alpha , but not TBP - 1 , and does not promote degradation of Hif1 alpha'
p1089
(lp1090
I1
a(lp1091
I24
aI25
atp1092
a(I-1
S'A pVHL mutant containing a P154L substitution coimmunoprecipitates with Hif1 alpha , but not TBP - 1 , and does not promote degradation of Hif1 alpha'
p1093
(lp1094
I9
aI10
a(lp1095
I14
aI15
aI16
atp1096
a(I-1
S'A pVHL mutant containing a P154L substitution coimmunoprecipitates with Hif1 alpha , but not TBP - 1 , and does not promote degradation of Hif1 alpha'
p1097
(lp1098
I9
aI10
a(lp1099
I24
aI25
atp1100
a(I-1
S'A pVHL mutant containing a P154L substitution coimmunoprecipitates with Hif1 alpha , but not TBP - 1 , and does not promote degradation of Hif1 alpha'
p1101
(lp1102
I14
aI15
aI16
a(lp1103
I24
aI25
atp1104
a(I1
S'Thus , the ability of pVHL to degrade Hif1 alpha depends in part on its interaction with TBP - 1 and suggests a new mechanism for Hif1 alpha stabilization in some pVHL - deficient tumors'
p1105
(lp1106
I5
a(lp1107
I8
aI9
atp1108
a(I1
S'Thus , the ability of pVHL to degrade Hif1 alpha depends in part on its interaction with TBP - 1 and suggests a new mechanism for Hif1 alpha stabilization in some pVHL - deficient tumors'
p1109
(lp1110
I5
a(lp1111
I17
aI18
aI19
atp1112
a(I-1
S'Thus , the ability of pVHL to degrade Hif1 alpha depends in part on its interaction with TBP - 1 and suggests a new mechanism for Hif1 alpha stabilization in some pVHL - deficient tumors'
p1113
(lp1114
I5
a(lp1115
I26
aI27
atp1116
a(I-1
S'Thus , the ability of pVHL to degrade Hif1 alpha depends in part on its interaction with TBP - 1 and suggests a new mechanism for Hif1 alpha stabilization in some pVHL - deficient tumors'
p1117
(lp1118
I5
a(lp1119
I31
atp1120
a(I-1
S'Thus , the ability of pVHL to degrade Hif1 alpha depends in part on its interaction with TBP - 1 and suggests a new mechanism for Hif1 alpha stabilization in some pVHL - deficient tumors'
p1121
(lp1122
I8
aI9
a(lp1123
I17
aI18
aI19
atp1124
a(I-1
S'Thus , the ability of pVHL to degrade Hif1 alpha depends in part on its interaction with TBP - 1 and suggests a new mechanism for Hif1 alpha stabilization in some pVHL - deficient tumors'
p1125
(lp1126
I8
aI9
a(lp1127
I26
aI27
atp1128
a(I-1
S'Thus , the ability of pVHL to degrade Hif1 alpha depends in part on its interaction with TBP - 1 and suggests a new mechanism for Hif1 alpha stabilization in some pVHL - deficient tumors'
p1129
(lp1130
I8
aI9
a(lp1131
I31
atp1132
a(I-1
S'Thus , the ability of pVHL to degrade Hif1 alpha depends in part on its interaction with TBP - 1 and suggests a new mechanism for Hif1 alpha stabilization in some pVHL - deficient tumors'
p1133
(lp1134
I17
aI18
aI19
a(lp1135
I26
aI27
atp1136
a(I-1
S'Thus , the ability of pVHL to degrade Hif1 alpha depends in part on its interaction with TBP - 1 and suggests a new mechanism for Hif1 alpha stabilization in some pVHL - deficient tumors'
p1137
(lp1138
I17
aI18
aI19
a(lp1139
I31
atp1140
a(I1
S'Thus , the ability of pVHL to degrade Hif1 alpha depends in part on its interaction with TBP - 1 and suggests a new mechanism for Hif1 alpha stabilization in some pVHL - deficient tumors'
p1141
(lp1142
I26
aI27
a(lp1143
I31
atp1144
a(I-1
S'Pinin / DRS / memA interacts with SRp75 , SRm300 and SRrp130 in corneal epithelial cells'
p1145
(lp1146
I0
a(lp1147
I2
atp1148
a(I1
S'Pinin / DRS / memA interacts with SRp75 , SRm300 and SRrp130 in corneal epithelial cells'
p1149
(lp1150
I0
a(lp1151
I7
atp1152
a(I1
S'Pinin / DRS / memA interacts with SRp75 , SRm300 and SRrp130 in corneal epithelial cells'
p1153
(lp1154
I0
a(lp1155
I9
atp1156
a(I1
S'Pinin / DRS / memA interacts with SRp75 , SRm300 and SRrp130 in corneal epithelial cells'
p1157
(lp1158
I2
a(lp1159
I7
atp1160
a(I1
S'Pinin / DRS / memA interacts with SRp75 , SRm300 and SRrp130 in corneal epithelial cells'
p1161
(lp1162
I2
a(lp1163
I9
atp1164
a(I-1
S'Pinin / DRS / memA interacts with SRp75 , SRm300 and SRrp130 in corneal epithelial cells'
p1165
(lp1166
I7
a(lp1167
I9
atp1168
a(I-1
S'Three SR - rich proteins were identified that interact with the C - terminus of Pnn : SRp75 and SRm300 , known components of spliceosome machinery , and a novel 130 - kDa nuclear protein , SRrp130'
p1169
(lp1170
I17
a(lp1171
I19
atp1172
a(I1
S'We report that MSH2 ( MutS homolog 2 ) protein interacts with the ATR ( ATM - and Rad3 - related ) kinase to form a signaling module and regulate the phosphorylation of Chk1 and SMC1 ( structure maintenance of chromosome 1 )'
p1173
(lp1174
I3
a(lp1175
I33
atp1176
a(I1
S'We report that MSH2 ( MutS homolog 2 ) protein interacts with the ATR ( ATM - and Rad3 - related ) kinase to form a signaling module and regulate the phosphorylation of Chk1 and SMC1 ( structure maintenance of chromosome 1 )'
p1177
(lp1178
I3
a(lp1179
I35
atp1180
a(I-1
S'We report that MSH2 ( MutS homolog 2 ) protein interacts with the ATR ( ATM - and Rad3 - related ) kinase to form a signaling module and regulate the phosphorylation of Chk1 and SMC1 ( structure maintenance of chromosome 1 )'
p1181
(lp1182
I33
a(lp1183
I35
atp1184
a(I1
S'We found that phosphorylation of Chk1 by ATR also requires checkpoint proteins Rad17 and replication protein A'
p1185
(lp1186
I5
a(lp1187
I12
atp1188
a(I-1
S'In contrast , phosphorylation of SMC1 by ATR is independent of Rad17 and replication protein A , suggesting that the signaling pathway leading to SMC1 phosphorylation is distinct from that mediated by the checkpoint proteins'
p1189
(lp1190
I5
a(lp1191
I11
atp1192
a(I-1
S'In contrast , phosphorylation of SMC1 by ATR is independent of Rad17 and replication protein A , suggesting that the signaling pathway leading to SMC1 phosphorylation is distinct from that mediated by the checkpoint proteins'
p1193
(lp1194
I5
a(lp1195
I24
atp1196
a(I-1
S'In contrast , phosphorylation of SMC1 by ATR is independent of Rad17 and replication protein A , suggesting that the signaling pathway leading to SMC1 phosphorylation is distinct from that mediated by the checkpoint proteins'
p1197
(lp1198
I11
a(lp1199
I24
atp1200
a(I-1
S'In addition , both MSH2 and Rad17 are required for the activation of the S - phase checkpoint to suppress DNA synthesis in response to MNNG , and phosphorylation of SMC1 is required for cellular survival'
p1201
(lp1202
I4
a(lp1203
I6
atp1204
a(I-1
S'In addition , both MSH2 and Rad17 are required for the activation of the S - phase checkpoint to suppress DNA synthesis in response to MNNG , and phosphorylation of SMC1 is required for cellular survival'
p1205
(lp1206
I4
a(lp1207
I30
atp1208
a(I-1
S'In addition , both MSH2 and Rad17 are required for the activation of the S - phase checkpoint to suppress DNA synthesis in response to MNNG , and phosphorylation of SMC1 is required for cellular survival'
p1209
(lp1210
I6
a(lp1211
I30
atp1212
a(I1
S'Modification of de novo DNA methyltransferase 3a ( Dnmt3a ) by SUMO - 1 modulates its interaction with histone deacetylases ( HDACs ) and its capacity to repress transcription'
p1213
(lp1214
I8
a(lp1215
I11
aI12
aI13
atp1216
a(I1
S'Here we show that Dnmt3a interacts with multiple components of the sumoylation machinery , namely the E2 sumo conjugating enzyme Ubc9 and the E3 sumo ligases PIAS1 and PIASxalpha , all of which are involved in conjugating the small ubiquitin - like modifier polypeptide , SUMO - 1 , to its target proteins'
p1217
(lp1218
I4
a(lp1219
I20
atp1220
a(I1
S'Here we show that Dnmt3a interacts with multiple components of the sumoylation machinery , namely the E2 sumo conjugating enzyme Ubc9 and the E3 sumo ligases PIAS1 and PIASxalpha , all of which are involved in conjugating the small ubiquitin - like modifier polypeptide , SUMO - 1 , to its target proteins'
p1221
(lp1222
I4
a(lp1223
I26
atp1224
a(I1
S'Here we show that Dnmt3a interacts with multiple components of the sumoylation machinery , namely the E2 sumo conjugating enzyme Ubc9 and the E3 sumo ligases PIAS1 and PIASxalpha , all of which are involved in conjugating the small ubiquitin - like modifier polypeptide , SUMO - 1 , to its target proteins'
p1225
(lp1226
I4
a(lp1227
I28
atp1228
a(I-1
S'Here we show that Dnmt3a interacts with multiple components of the sumoylation machinery , namely the E2 sumo conjugating enzyme Ubc9 and the E3 sumo ligases PIAS1 and PIASxalpha , all of which are involved in conjugating the small ubiquitin - like modifier polypeptide , SUMO - 1 , to its target proteins'
p1229
(lp1230
I4
a(lp1231
I45
aI46
aI47
atp1232
a(I-1
S'Here we show that Dnmt3a interacts with multiple components of the sumoylation machinery , namely the E2 sumo conjugating enzyme Ubc9 and the E3 sumo ligases PIAS1 and PIASxalpha , all of which are involved in conjugating the small ubiquitin - like modifier polypeptide , SUMO - 1 , to its target proteins'
p1233
(lp1234
I20
a(lp1235
I26
atp1236
a(I-1
S'Here we show that Dnmt3a interacts with multiple components of the sumoylation machinery , namely the E2 sumo conjugating enzyme Ubc9 and the E3 sumo ligases PIAS1 and PIASxalpha , all of which are involved in conjugating the small ubiquitin - like modifier polypeptide , SUMO - 1 , to its target proteins'
p1237
(lp1238
I20
a(lp1239
I28
atp1240
a(I1
S'Here we show that Dnmt3a interacts with multiple components of the sumoylation machinery , namely the E2 sumo conjugating enzyme Ubc9 and the E3 sumo ligases PIAS1 and PIASxalpha , all of which are involved in conjugating the small ubiquitin - like modifier polypeptide , SUMO - 1 , to its target proteins'
p1241
(lp1242
I20
a(lp1243
I45
aI46
aI47
atp1244
a(I-1
S'Here we show that Dnmt3a interacts with multiple components of the sumoylation machinery , namely the E2 sumo conjugating enzyme Ubc9 and the E3 sumo ligases PIAS1 and PIASxalpha , all of which are involved in conjugating the small ubiquitin - like modifier polypeptide , SUMO - 1 , to its target proteins'
p1245
(lp1246
I26
a(lp1247
I28
atp1248
a(I1
S'Here we show that Dnmt3a interacts with multiple components of the sumoylation machinery , namely the E2 sumo conjugating enzyme Ubc9 and the E3 sumo ligases PIAS1 and PIASxalpha , all of which are involved in conjugating the small ubiquitin - like modifier polypeptide , SUMO - 1 , to its target proteins'
p1249
(lp1250
I26
a(lp1251
I45
aI46
aI47
atp1252
a(I1
S'Here we show that Dnmt3a interacts with multiple components of the sumoylation machinery , namely the E2 sumo conjugating enzyme Ubc9 and the E3 sumo ligases PIAS1 and PIASxalpha , all of which are involved in conjugating the small ubiquitin - like modifier polypeptide , SUMO - 1 , to its target proteins'
p1253
(lp1254
I28
a(lp1255
I45
aI46
aI47
atp1256
a(I1
S'Dnmt3a is modified by SUMO - 1 in vivo and in vitro and the region of Dnmt3a responsible for interaction maps to the N - terminal regulatory domain'
p1257
(lp1258
I0
a(lp1259
I4
aI5
aI6
atp1260
a(I-1
S'Dnmt3a is modified by SUMO - 1 in vivo and in vitro and the region of Dnmt3a responsible for interaction maps to the N - terminal regulatory domain'
p1261
(lp1262
I0
a(lp1263
I16
atp1264
a(I-1
S'Dnmt3a is modified by SUMO - 1 in vivo and in vitro and the region of Dnmt3a responsible for interaction maps to the N - terminal regulatory domain'
p1265
(lp1266
I4
aI5
aI6
a(lp1267
I16
atp1268
a(I1
S'Functionally , sumoylation of Dnmt3a disrupts its ability to interact with histone deacetylases ( HDAC1 / 2 ) , but not with another interaction partner , Dnmt3b'
p1269
(lp1270
I4
a(lp1271
I14
atp1272
a(I-1
S'Functionally , sumoylation of Dnmt3a disrupts its ability to interact with histone deacetylases ( HDAC1 / 2 ) , but not with another interaction partner , Dnmt3b'
p1273
(lp1274
I4
a(lp1275
I26
atp1276
a(I-1
S'Functionally , sumoylation of Dnmt3a disrupts its ability to interact with histone deacetylases ( HDAC1 / 2 ) , but not with another interaction partner , Dnmt3b'
p1277
(lp1278
I14
a(lp1279
I26
atp1280
a(I1
S'The tyrosine kinase Tyk - 2 is physically associated with the Type I interferon ( IFN ) receptor complex and is rapidly activated during IFN alpha stimulation'
p1281
(lp1282
I3
aI4
aI5
a(lp1283
I15
atp1284
a(I1
S'The tyrosine kinase Tyk - 2 is physically associated with the Type I interferon ( IFN ) receptor complex and is rapidly activated during IFN alpha stimulation'
p1285
(lp1286
I3
aI4
aI5
a(lp1287
I24
aI25
atp1288
a(I-1
S'The tyrosine kinase Tyk - 2 is physically associated with the Type I interferon ( IFN ) receptor complex and is rapidly activated during IFN alpha stimulation'
p1289
(lp1290
I15
a(lp1291
I24
aI25
atp1292
a(I1
S'Raf1 interaction with Cdc25 phosphatase ties mitogenic signal transduction to cell cycle activation'
p1293
(lp1294
I0
a(lp1295
I3
atp1296
a(I1
S'We show here that Cdc25 phosphatase associates with raf1 in somatic mammalian cells and in meiotic frog oocytes'
p1297
(lp1298
I4
a(lp1299
I8
atp1300
a(I-1
S"Differential binding of vascular cell - derived proteoglycans ( perlecan , biglycan , decorin , and versican ) to the beta - amyloid protein of Alzheimer ' s disease"
p1301
(lp1302
I9
a(lp1303
I11
atp1304
a(I-1
S"Differential binding of vascular cell - derived proteoglycans ( perlecan , biglycan , decorin , and versican ) to the beta - amyloid protein of Alzheimer ' s disease"
p1305
(lp1306
I9
a(lp1307
I13
atp1308
a(I-1
S"Differential binding of vascular cell - derived proteoglycans ( perlecan , biglycan , decorin , and versican ) to the beta - amyloid protein of Alzheimer ' s disease"
p1309
(lp1310
I9
a(lp1311
I16
atp1312
a(I-1
S"Differential binding of vascular cell - derived proteoglycans ( perlecan , biglycan , decorin , and versican ) to the beta - amyloid protein of Alzheimer ' s disease"
p1313
(lp1314
I11
a(lp1315
I13
atp1316
a(I-1
S"Differential binding of vascular cell - derived proteoglycans ( perlecan , biglycan , decorin , and versican ) to the beta - amyloid protein of Alzheimer ' s disease"
p1317
(lp1318
I11
a(lp1319
I16
atp1320
a(I-1
S"Differential binding of vascular cell - derived proteoglycans ( perlecan , biglycan , decorin , and versican ) to the beta - amyloid protein of Alzheimer ' s disease"
p1321
(lp1322
I13
a(lp1323
I16
atp1324
a(I-1
S"Previous studies have demonstrated the immunolocalization of perlecan , a specific heparan sulfate proteoglycan , to the beta - amyloid protein ( A beta ) - containing amyloid deposits within the walls of blood vessels ( i . e . , congophilic angiopathy ) in Alzheimer ' s disease ( AD ) brain"
p1325
(lp1326
I7
a(lp1327
I11
aI12
aI13
atp1328
a(I1
S"Previous studies have demonstrated the immunolocalization of perlecan , a specific heparan sulfate proteoglycan , to the beta - amyloid protein ( A beta ) - containing amyloid deposits within the walls of blood vessels ( i . e . , congophilic angiopathy ) in Alzheimer ' s disease ( AD ) brain"
p1329
(lp1330
I7
a(lp1331
I17
aI18
aI19
atp1332
a(I1
S"Previous studies have demonstrated the immunolocalization of perlecan , a specific heparan sulfate proteoglycan , to the beta - amyloid protein ( A beta ) - containing amyloid deposits within the walls of blood vessels ( i . e . , congophilic angiopathy ) in Alzheimer ' s disease ( AD ) brain"
p1333
(lp1334
I7
a(lp1335
I27
atp1336
a(I1
S"Previous studies have demonstrated the immunolocalization of perlecan , a specific heparan sulfate proteoglycan , to the beta - amyloid protein ( A beta ) - containing amyloid deposits within the walls of blood vessels ( i . e . , congophilic angiopathy ) in Alzheimer ' s disease ( AD ) brain"
p1337
(lp1338
I11
aI12
aI13
a(lp1339
I17
aI18
aI19
atp1340
a(I1
S"Previous studies have demonstrated the immunolocalization of perlecan , a specific heparan sulfate proteoglycan , to the beta - amyloid protein ( A beta ) - containing amyloid deposits within the walls of blood vessels ( i . e . , congophilic angiopathy ) in Alzheimer ' s disease ( AD ) brain"
p1341
(lp1342
I11
aI12
aI13
a(lp1343
I27
atp1344
a(I-1
S"Previous studies have demonstrated the immunolocalization of perlecan , a specific heparan sulfate proteoglycan , to the beta - amyloid protein ( A beta ) - containing amyloid deposits within the walls of blood vessels ( i . e . , congophilic angiopathy ) in Alzheimer ' s disease ( AD ) brain"
p1345
(lp1346
I17
aI18
aI19
a(lp1347
I27
atp1348
a(I-1
S'Overall , the results indicate that specific vascular cell - derived PGs differentially interact with A beta , and that the interactions of highest affinity occur between A beta and binding sites on both the core protein and glycosaminoglycan chains of perlecan'
p1349
(lp1350
I11
a(lp1351
I41
atp1352
a(I-1
S'In the present investigation , the differential binding of previously characterized endothelial cell ( EC ) - and smooth muscle cell ( SMC ) - derived PGs to A beta was examined to determine whether the accumulation of A beta in cerebrovascular amyloid deposits may be due to its interactions with perlecan'
p1353
(lp1354
I22
a(lp1355
I26
atp1356
a(I-1
S'In the present investigation , the differential binding of previously characterized endothelial cell ( EC ) - and smooth muscle cell ( SMC ) - derived PGs to A beta was examined to determine whether the accumulation of A beta in cerebrovascular amyloid deposits may be due to its interactions with perlecan'
p1357
(lp1358
I22
a(lp1359
I42
atp1360
a(I-1
S'In the present investigation , the differential binding of previously characterized endothelial cell ( EC ) - and smooth muscle cell ( SMC ) - derived PGs to A beta was examined to determine whether the accumulation of A beta in cerebrovascular amyloid deposits may be due to its interactions with perlecan'
p1361
(lp1362
I22
a(lp1363
I51
atp1364
a(I-1
S'In the present investigation , the differential binding of previously characterized endothelial cell ( EC ) - and smooth muscle cell ( SMC ) - derived PGs to A beta was examined to determine whether the accumulation of A beta in cerebrovascular amyloid deposits may be due to its interactions with perlecan'
p1365
(lp1366
I26
a(lp1367
I42
atp1368
a(I-1
S'In the present investigation , the differential binding of previously characterized endothelial cell ( EC ) - and smooth muscle cell ( SMC ) - derived PGs to A beta was examined to determine whether the accumulation of A beta in cerebrovascular amyloid deposits may be due to its interactions with perlecan'
p1369
(lp1370
I26
a(lp1371
I51
atp1372
a(I-1
S'In the present investigation , the differential binding of previously characterized endothelial cell ( EC ) - and smooth muscle cell ( SMC ) - derived PGs to A beta was examined to determine whether the accumulation of A beta in cerebrovascular amyloid deposits may be due to its interactions with perlecan'
p1373
(lp1374
I42
a(lp1375
I51
atp1376
a(I-1
S'Pretreatment of AA amyloidotic splenic and liver tissue sections with synthetic A beta ( 1 - 28 ) produced strong immunoreactivity with A beta antibodies at tissue sites enriched in perlecan which was partially removed by pretreatment with heparitinase , but not by chondroitin ABC lyase'
p1377
(lp1378
I30
a(lp1379
I44
atp1380
a(I-1
S'[ 35S ] - Sulfate labeled proteoglycans ( PGs ) derived from cultured ECs and SMCs bound to affinity columns containing A beta ( 1 - 28 ) or ( 1 - 40 ) , with virtually no binding to A beta ( 40 - 1 ) ( reverse peptide ) , beta - amyloid precursor protein ( 410 - 429 ) , or bovine serum albumin'
p1381
(lp1382
I8
a(lp1383
I65
aI66
atp1384
a(I-1
S'Characterization of EC and SMC PGs bound to A beta ( 1 - 28 ) revealed strong binding by perlecan , weak binding by decorin and biglycan , two dermatan sulfate proteoglycans , and lack of binding by versican / PG - M , a large chondroitin sulfate proteoglycan'
p1385
(lp1386
I4
a(lp1387
I5
atp1388
a(I-1
S'Characterization of EC and SMC PGs bound to A beta ( 1 - 28 ) revealed strong binding by perlecan , weak binding by decorin and biglycan , two dermatan sulfate proteoglycans , and lack of binding by versican / PG - M , a large chondroitin sulfate proteoglycan'
p1389
(lp1390
I4
a(lp1391
I19
atp1392
a(I-1
S'Characterization of EC and SMC PGs bound to A beta ( 1 - 28 ) revealed strong binding by perlecan , weak binding by decorin and biglycan , two dermatan sulfate proteoglycans , and lack of binding by versican / PG - M , a large chondroitin sulfate proteoglycan'
p1393
(lp1394
I4
a(lp1395
I24
atp1396
a(I-1
S'Characterization of EC and SMC PGs bound to A beta ( 1 - 28 ) revealed strong binding by perlecan , weak binding by decorin and biglycan , two dermatan sulfate proteoglycans , and lack of binding by versican / PG - M , a large chondroitin sulfate proteoglycan'
p1397
(lp1398
I4
a(lp1399
I26
atp1400
a(I-1
S'Characterization of EC and SMC PGs bound to A beta ( 1 - 28 ) revealed strong binding by perlecan , weak binding by decorin and biglycan , two dermatan sulfate proteoglycans , and lack of binding by versican / PG - M , a large chondroitin sulfate proteoglycan'
p1401
(lp1402
I4
a(lp1403
I38
atp1404
a(I-1
S'Characterization of EC and SMC PGs bound to A beta ( 1 - 28 ) revealed strong binding by perlecan , weak binding by decorin and biglycan , two dermatan sulfate proteoglycans , and lack of binding by versican / PG - M , a large chondroitin sulfate proteoglycan'
p1405
(lp1406
I4
a(lp1407
I40
aI41
aI42
atp1408
a(I1
S'Characterization of EC and SMC PGs bound to A beta ( 1 - 28 ) revealed strong binding by perlecan , weak binding by decorin and biglycan , two dermatan sulfate proteoglycans , and lack of binding by versican / PG - M , a large chondroitin sulfate proteoglycan'
p1409
(lp1410
I5
a(lp1411
I19
atp1412
a(I1
S'Characterization of EC and SMC PGs bound to A beta ( 1 - 28 ) revealed strong binding by perlecan , weak binding by decorin and biglycan , two dermatan sulfate proteoglycans , and lack of binding by versican / PG - M , a large chondroitin sulfate proteoglycan'
p1413
(lp1414
I5
a(lp1415
I24
atp1416
a(I1
S'Characterization of EC and SMC PGs bound to A beta ( 1 - 28 ) revealed strong binding by perlecan , weak binding by decorin and biglycan , two dermatan sulfate proteoglycans , and lack of binding by versican / PG - M , a large chondroitin sulfate proteoglycan'
p1417
(lp1418
I5
a(lp1419
I26
atp1420
a(I-1
S'Characterization of EC and SMC PGs bound to A beta ( 1 - 28 ) revealed strong binding by perlecan , weak binding by decorin and biglycan , two dermatan sulfate proteoglycans , and lack of binding by versican / PG - M , a large chondroitin sulfate proteoglycan'
p1421
(lp1422
I5
a(lp1423
I38
atp1424
a(I-1
S'Characterization of EC and SMC PGs bound to A beta ( 1 - 28 ) revealed strong binding by perlecan , weak binding by decorin and biglycan , two dermatan sulfate proteoglycans , and lack of binding by versican / PG - M , a large chondroitin sulfate proteoglycan'
p1425
(lp1426
I5
a(lp1427
I40
aI41
aI42
atp1428
a(I-1
S'Characterization of EC and SMC PGs bound to A beta ( 1 - 28 ) revealed strong binding by perlecan , weak binding by decorin and biglycan , two dermatan sulfate proteoglycans , and lack of binding by versican / PG - M , a large chondroitin sulfate proteoglycan'
p1429
(lp1430
I19
a(lp1431
I24
atp1432
a(I-1
S'Characterization of EC and SMC PGs bound to A beta ( 1 - 28 ) revealed strong binding by perlecan , weak binding by decorin and biglycan , two dermatan sulfate proteoglycans , and lack of binding by versican / PG - M , a large chondroitin sulfate proteoglycan'
p1433
(lp1434
I19
a(lp1435
I26
atp1436
a(I-1
S'Characterization of EC and SMC PGs bound to A beta ( 1 - 28 ) revealed strong binding by perlecan , weak binding by decorin and biglycan , two dermatan sulfate proteoglycans , and lack of binding by versican / PG - M , a large chondroitin sulfate proteoglycan'
p1437
(lp1438
I19
a(lp1439
I38
atp1440
a(I-1
S'Characterization of EC and SMC PGs bound to A beta ( 1 - 28 ) revealed strong binding by perlecan , weak binding by decorin and biglycan , two dermatan sulfate proteoglycans , and lack of binding by versican / PG - M , a large chondroitin sulfate proteoglycan'
p1441
(lp1442
I19
a(lp1443
I40
aI41
aI42
atp1444
a(I-1
S'Characterization of EC and SMC PGs bound to A beta ( 1 - 28 ) revealed strong binding by perlecan , weak binding by decorin and biglycan , two dermatan sulfate proteoglycans , and lack of binding by versican / PG - M , a large chondroitin sulfate proteoglycan'
p1445
(lp1446
I24
a(lp1447
I26
atp1448
a(I-1
S'Characterization of EC and SMC PGs bound to A beta ( 1 - 28 ) revealed strong binding by perlecan , weak binding by decorin and biglycan , two dermatan sulfate proteoglycans , and lack of binding by versican / PG - M , a large chondroitin sulfate proteoglycan'
p1449
(lp1450
I24
a(lp1451
I38
atp1452
a(I-1
S'Characterization of EC and SMC PGs bound to A beta ( 1 - 28 ) revealed strong binding by perlecan , weak binding by decorin and biglycan , two dermatan sulfate proteoglycans , and lack of binding by versican / PG - M , a large chondroitin sulfate proteoglycan'
p1453
(lp1454
I24
a(lp1455
I40
aI41
aI42
atp1456
a(I-1
S'Characterization of EC and SMC PGs bound to A beta ( 1 - 28 ) revealed strong binding by perlecan , weak binding by decorin and biglycan , two dermatan sulfate proteoglycans , and lack of binding by versican / PG - M , a large chondroitin sulfate proteoglycan'
p1457
(lp1458
I26
a(lp1459
I38
atp1460
a(I-1
S'Characterization of EC and SMC PGs bound to A beta ( 1 - 28 ) revealed strong binding by perlecan , weak binding by decorin and biglycan , two dermatan sulfate proteoglycans , and lack of binding by versican / PG - M , a large chondroitin sulfate proteoglycan'
p1461
(lp1462
I26
a(lp1463
I40
aI41
aI42
atp1464
a(I-1
S'Characterization of EC and SMC PGs bound to A beta ( 1 - 28 ) revealed strong binding by perlecan , weak binding by decorin and biglycan , two dermatan sulfate proteoglycans , and lack of binding by versican / PG - M , a large chondroitin sulfate proteoglycan'
p1465
(lp1466
I38
a(lp1467
I40
aI41
aI42
atp1468
a(I1
S'Cross - linking of CD53 with the use of the mAb MEM - 53 and a polyclonal sheep anti - mouse Ig promoted activation of resting B cells into the G1 phase of the cell cycle as judged by increased expression of the early activation Ag CD69 , increases in cellular volume , RNA synthesis , and c - myc protein levels , and enhanced binding of 7 - aminoactinomycin D'
p1469
(lp1470
I4
a(lp1471
I46
atp1472
a(I1
S'Cross - linking of CD53 with the use of the mAb MEM - 53 and a polyclonal sheep anti - mouse Ig promoted activation of resting B cells into the G1 phase of the cell cycle as judged by increased expression of the early activation Ag CD69 , increases in cellular volume , RNA synthesis , and c - myc protein levels , and enhanced binding of 7 - aminoactinomycin D'
p1473
(lp1474
I4
a(lp1475
I57
aI58
aI59
atp1476
a(I-1
S'Cross - linking of CD53 with the use of the mAb MEM - 53 and a polyclonal sheep anti - mouse Ig promoted activation of resting B cells into the G1 phase of the cell cycle as judged by increased expression of the early activation Ag CD69 , increases in cellular volume , RNA synthesis , and c - myc protein levels , and enhanced binding of 7 - aminoactinomycin D'
p1477
(lp1478
I46
a(lp1479
I57
aI58
aI59
atp1480
a(I-1
S'However , cytokines , in particular IL - 2 and IL - 4 , potentiated the DNA synthesis induced by cross - linking of CD53'
p1481
(lp1482
I6
aI7
aI8
a(lp1483
I10
aI11
aI12
atp1484
a(I1
S'However , cytokines , in particular IL - 2 and IL - 4 , potentiated the DNA synthesis induced by cross - linking of CD53'
p1485
(lp1486
I6
aI7
aI8
a(lp1487
I24
atp1488
a(I1
S'However , cytokines , in particular IL - 2 and IL - 4 , potentiated the DNA synthesis induced by cross - linking of CD53'
p1489
(lp1490
I10
aI11
aI12
a(lp1491
I24
atp1492
a(I-1
S'The human apoB mRNA editing protein is a cytidine deaminase showing structural homology to some known mammalian and bacteriophage deoxycytidylate deaminases'
p1493
(lp1494
I2
a(lp1495
I8
aI9
atp1496
a(I-1
S'The fact that the apoB mRNA editing protein also exists as a homodimer has important implications for the mechanism of apoB mRNA editing in humans'
p1497
(lp1498
I4
a(lp1499
I12
atp1500
a(I-1
S'The fact that the apoB mRNA editing protein also exists as a homodimer has important implications for the mechanism of apoB mRNA editing in humans'
p1501
(lp1502
I4
a(lp1503
I20
atp1504
a(I-1
S'The fact that the apoB mRNA editing protein also exists as a homodimer has important implications for the mechanism of apoB mRNA editing in humans'
p1505
(lp1506
I12
a(lp1507
I20
atp1508
a(I-1
S'Assignment of Etfdh , Etfb , and Etfa to chromosomes 3 , 7 , and 13 : the mouse homologs of genes responsible for glutaric acidemia type II in human'
p1509
(lp1510
I2
a(lp1511
I4
atp1512
a(I-1
S'We used cDNA probes for the Etfdh , Etfb , and Etfa genes to determine localization of these mouse genes to chromosomes 3 , 7 , and 13'
p1513
(lp1514
I6
a(lp1515
I8
atp1516
a(I1
S'CD22 associates with protein tyrosine phosphatase 1C , Syk , and phospholipase C - gamma ( 1 ) upon B cell activation'
p1517
(lp1518
I0
a(lp1519
I3
aI4
aI5
aI6
atp1520
a(I1
S'These results suggest that tyrosyl - phosphorylated CD22 may be a substrate for PTP - 1C regulates tyrosyl phosphorylation of CD22'
p1521
(lp1522
I7
a(lp1523
I13
aI14
aI15
atp1524
a(I-1
S'These results suggest that tyrosyl - phosphorylated CD22 may be a substrate for PTP - 1C regulates tyrosyl phosphorylation of CD22'
p1525
(lp1526
I7
a(lp1527
I20
atp1528
a(I1
S'These results suggest that tyrosyl - phosphorylated CD22 may be a substrate for PTP - 1C regulates tyrosyl phosphorylation of CD22'
p1529
(lp1530
I13
aI14
aI15
a(lp1531
I20
atp1532
a(I1
S'The association of PTP - 1C with CD22 was mediated by the NH2 - terminal Src homology 2 ( SH2 ) domain of PTP - 1C'
p1533
(lp1534
I3
aI4
aI5
a(lp1535
I7
atp1536
a(I-1
S'The association of PTP - 1C with CD22 was mediated by the NH2 - terminal Src homology 2 ( SH2 ) domain of PTP - 1C'
p1537
(lp1538
I3
aI4
aI5
a(lp1539
I23
aI24
aI25
atp1540
a(I1
S'The association of PTP - 1C with CD22 was mediated by the NH2 - terminal Src homology 2 ( SH2 ) domain of PTP - 1C'
p1541
(lp1542
I7
a(lp1543
I23
aI24
aI25
atp1544
a(I1
S'Complexes of either CD22 / PTP - 1C / Syk / PLC - gamma ( 1 ) could be isolated from B cells stimulated by BCR engagement or a mixture of hydrogen peroxidase and sodium orthovanadate , respectively'
p1545
(lp1546
I3
a(lp1547
I5
aI6
aI7
atp1548
a(I-1
S'Transient expression of CD22 and a null mutant of PTP - 1C ( PTP - 1CM ) in COS cells resulted in an increase in tyrosyl phosphorylation of CD22 and its interaction with PTP - 1CM'
p1549
(lp1550
I3
a(lp1551
I9
aI10
aI11
atp1552
a(I-1
S'Transient expression of CD22 and a null mutant of PTP - 1C ( PTP - 1CM ) in COS cells resulted in an increase in tyrosyl phosphorylation of CD22 and its interaction with PTP - 1CM'
p1553
(lp1554
I3
a(lp1555
I28
atp1556
a(I1
S'Transient expression of CD22 and a null mutant of PTP - 1C ( PTP - 1CM ) in COS cells resulted in an increase in tyrosyl phosphorylation of CD22 and its interaction with PTP - 1CM'
p1557
(lp1558
I9
aI10
aI11
a(lp1559
I28
atp1560
a(I-1
S'By contrast , CD22 was not tyrosyl phosphorylated or associated with PTP - 1CM in the presence of wild - type PTP - 1C'
p1561
(lp1562
I3
a(lp1563
I21
aI22
aI23
atp1564
a(I-1
S'TFIID dimers formed through self - association of the TATA - binding polypeptide ( TBP ) subunit and could be immunoprecipitated with antibodies to TAF ( II ) 250 , the core subunit of TFIID'
p1565
(lp1566
I0
a(lp1567
I14
atp1568
a(I1
S'TFIID dimers formed through self - association of the TATA - binding polypeptide ( TBP ) subunit and could be immunoprecipitated with antibodies to TAF ( II ) 250 , the core subunit of TFIID'
p1569
(lp1570
I0
a(lp1571
I24
aI25
aI26
aI27
aI28
atp1572
a(I-1
S'TFIID dimers formed through self - association of the TATA - binding polypeptide ( TBP ) subunit and could be immunoprecipitated with antibodies to TAF ( II ) 250 , the core subunit of TFIID'
p1573
(lp1574
I0
a(lp1575
I34
atp1576
a(I-1
S'TFIID dimers formed through self - association of the TATA - binding polypeptide ( TBP ) subunit and could be immunoprecipitated with antibodies to TAF ( II ) 250 , the core subunit of TFIID'
p1577
(lp1578
I14
a(lp1579
I24
aI25
aI26
aI27
aI28
atp1580
a(I-1
S'TFIID dimers formed through self - association of the TATA - binding polypeptide ( TBP ) subunit and could be immunoprecipitated with antibodies to TAF ( II ) 250 , the core subunit of TFIID'
p1581
(lp1582
I14
a(lp1583
I34
atp1584
a(I1
S'TFIID dimers formed through self - association of the TATA - binding polypeptide ( TBP ) subunit and could be immunoprecipitated with antibodies to TAF ( II ) 250 , the core subunit of TFIID'
p1585
(lp1586
I24
aI25
aI26
aI27
aI28
a(lp1587
I34
atp1588
a(I1
S'Subsequent amino acid sequencing revealed many peptides involving involucrin cross - linked either to itself or to a variety of other known CE protein components , including cystatin alpha , desmoplakin , elafin , keratins , members of the small proline - rich superfamily , loricrin , and unknown proteins related to the desmoplakin family'
p1589
(lp1590
I8
a(lp1591
I27
aI28
atp1592
a(I1
S'Subsequent amino acid sequencing revealed many peptides involving involucrin cross - linked either to itself or to a variety of other known CE protein components , including cystatin alpha , desmoplakin , elafin , keratins , members of the small proline - rich superfamily , loricrin , and unknown proteins related to the desmoplakin family'
p1593
(lp1594
I8
a(lp1595
I30
atp1596
a(I1
S'Subsequent amino acid sequencing revealed many peptides involving involucrin cross - linked either to itself or to a variety of other known CE protein components , including cystatin alpha , desmoplakin , elafin , keratins , members of the small proline - rich superfamily , loricrin , and unknown proteins related to the desmoplakin family'
p1597
(lp1598
I8
a(lp1599
I32
atp1600
a(I1
S'Subsequent amino acid sequencing revealed many peptides involving involucrin cross - linked either to itself or to a variety of other known CE protein components , including cystatin alpha , desmoplakin , elafin , keratins , members of the small proline - rich superfamily , loricrin , and unknown proteins related to the desmoplakin family'
p1601
(lp1602
I8
a(lp1603
I45
atp1604
a(I1
S'Subsequent amino acid sequencing revealed many peptides involving involucrin cross - linked either to itself or to a variety of other known CE protein components , including cystatin alpha , desmoplakin , elafin , keratins , members of the small proline - rich superfamily , loricrin , and unknown proteins related to the desmoplakin family'
p1605
(lp1606
I8
a(lp1607
I53
atp1608
a(I-1
S'Subsequent amino acid sequencing revealed many peptides involving involucrin cross - linked either to itself or to a variety of other known CE protein components , including cystatin alpha , desmoplakin , elafin , keratins , members of the small proline - rich superfamily , loricrin , and unknown proteins related to the desmoplakin family'
p1609
(lp1610
I27
aI28
a(lp1611
I30
atp1612
a(I-1
S'Subsequent amino acid sequencing revealed many peptides involving involucrin cross - linked either to itself or to a variety of other known CE protein components , including cystatin alpha , desmoplakin , elafin , keratins , members of the small proline - rich superfamily , loricrin , and unknown proteins related to the desmoplakin family'
p1613
(lp1614
I27
aI28
a(lp1615
I32
atp1616
a(I-1
S'Subsequent amino acid sequencing revealed many peptides involving involucrin cross - linked either to itself or to a variety of other known CE protein components , including cystatin alpha , desmoplakin , elafin , keratins , members of the small proline - rich superfamily , loricrin , and unknown proteins related to the desmoplakin family'
p1617
(lp1618
I27
aI28
a(lp1619
I45
atp1620
a(I-1
S'Subsequent amino acid sequencing revealed many peptides involving involucrin cross - linked either to itself or to a variety of other known CE protein components , including cystatin alpha , desmoplakin , elafin , keratins , members of the small proline - rich superfamily , loricrin , and unknown proteins related to the desmoplakin family'
p1621
(lp1622
I27
aI28
a(lp1623
I53
atp1624
a(I-1
S'Subsequent amino acid sequencing revealed many peptides involving involucrin cross - linked either to itself or to a variety of other known CE protein components , including cystatin alpha , desmoplakin , elafin , keratins , members of the small proline - rich superfamily , loricrin , and unknown proteins related to the desmoplakin family'
p1625
(lp1626
I30
a(lp1627
I32
atp1628
a(I-1
S'Subsequent amino acid sequencing revealed many peptides involving involucrin cross - linked either to itself or to a variety of other known CE protein components , including cystatin alpha , desmoplakin , elafin , keratins , members of the small proline - rich superfamily , loricrin , and unknown proteins related to the desmoplakin family'
p1629
(lp1630
I30
a(lp1631
I45
atp1632
a(I-1
S'Subsequent amino acid sequencing revealed many peptides involving involucrin cross - linked either to itself or to a variety of other known CE protein components , including cystatin alpha , desmoplakin , elafin , keratins , members of the small proline - rich superfamily , loricrin , and unknown proteins related to the desmoplakin family'
p1633
(lp1634
I30
a(lp1635
I53
atp1636
a(I-1
S'Subsequent amino acid sequencing revealed many peptides involving involucrin cross - linked either to itself or to a variety of other known CE protein components , including cystatin alpha , desmoplakin , elafin , keratins , members of the small proline - rich superfamily , loricrin , and unknown proteins related to the desmoplakin family'
p1637
(lp1638
I32
a(lp1639
I45
atp1640
a(I-1
S'Subsequent amino acid sequencing revealed many peptides involving involucrin cross - linked either to itself or to a variety of other known CE protein components , including cystatin alpha , desmoplakin , elafin , keratins , members of the small proline - rich superfamily , loricrin , and unknown proteins related to the desmoplakin family'
p1641
(lp1642
I32
a(lp1643
I53
atp1644
a(I-1
S'Subsequent amino acid sequencing revealed many peptides involving involucrin cross - linked either to itself or to a variety of other known CE protein components , including cystatin alpha , desmoplakin , elafin , keratins , members of the small proline - rich superfamily , loricrin , and unknown proteins related to the desmoplakin family'
p1645
(lp1646
I45
a(lp1647
I53
atp1648
a(I-1
S'Specific glutamines or lysines of involucrin were used to cross - link the different proteins , such as glutamines 495 and 496 to desmoplakin , glutamine 288 to keratins , and lysines 468 , 485 , and 508 and glutamines 465 and 489 for interchain involucrin cross - links'
p1649
(lp1650
I5
a(lp1651
I23
atp1652
a(I-1
S'Specific glutamines or lysines of involucrin were used to cross - link the different proteins , such as glutamines 495 and 496 to desmoplakin , glutamine 288 to keratins , and lysines 468 , 485 , and 508 and glutamines 465 and 489 for interchain involucrin cross - links'
p1653
(lp1654
I5
a(lp1655
I45
atp1656
a(I-1
S'Specific glutamines or lysines of involucrin were used to cross - link the different proteins , such as glutamines 495 and 496 to desmoplakin , glutamine 288 to keratins , and lysines 468 , 485 , and 508 and glutamines 465 and 489 for interchain involucrin cross - links'
p1657
(lp1658
I23
a(lp1659
I45
atp1660
a(I-1
S'A prominent isolate , designated SRcyp / CASP10 , specifically interacts with the CTD not only in vivo but also in vitro'
p1661
(lp1662
I5
a(lp1663
I7
atp1664
a(I1
S'A prominent isolate , designated SRcyp / CASP10 , specifically interacts with the CTD not only in vivo but also in vitro'
p1665
(lp1666
I5
a(lp1667
I13
atp1668
a(I1
S'A prominent isolate , designated SRcyp / CASP10 , specifically interacts with the CTD not only in vivo but also in vitro'
p1669
(lp1670
I7
a(lp1671
I13
atp1672
a(I-1
S'SRcyp is a nuclear protein with a characteristic distribution in large irregularly shaped nuclear speckles and co - localizes perfectly with the SR domain - containing splicing factor SC35'
p1673
(lp1674
I0
a(lp1675
I26
aI27
aI28
atp1676
a(I1
S'Transient expression of the full - length E2 - 2 without RSRS in U1240MG glioblastoma cells resulted in repression of FGF - 1 . B promoter activity'
p1677
(lp1678
I7
aI8
aI9
a(lp1679
I20
aI21
aI22
aI23
aI24
atp1680
a(I1
S'These results suggest that the relative abundance of the two splice variants of E2 - 2 in brain could be an important determinant for the expression of FGF - 1'
p1681
(lp1682
I13
aI14
aI15
a(lp1683
I27
aI28
aI29
atp1684
a(I1
S'We report here that PLZF , and a structurally similar transcriptional repressor , BCL - 6 , can interact with a variety of corepressor proteins in addition to SMRT , including the mSin3A protein and ( for PLZF ) histone deacetylase - 1'
p1685
(lp1686
I13
aI14
aI15
a(lp1687
I39
aI40
aI41
aI42
atp1688
a(I-1
S'Herein , we show that a distinct IkappaB protein Bcl3 also interacts with RXR , as shown in the yeast two - hybrid tests and glutathione S - transferase pull - down assays'
p1689
(lp1690
I9
a(lp1691
I25
aI26
aI27
aI28
atp1692
a(I-1
S'In contrast to IkappaBbeta , Bcl3 did not interact with the AF2 domain of RXR'
p1693
(lp1694
I3
a(lp1695
I5
atp1696
a(I1
S'Bcl3 specifically interacted with the general transcription factors TFIIB , TBP , and TFIIA but not with TFIIEalpha in the GST pull - down assays'
p1697
(lp1698
I0
a(lp1699
I8
atp1700
a(I1
S'Bcl3 specifically interacted with the general transcription factors TFIIB , TBP , and TFIIA but not with TFIIEalpha in the GST pull - down assays'
p1701
(lp1702
I0
a(lp1703
I13
atp1704
a(I-1
S'Bcl3 specifically interacted with the general transcription factors TFIIB , TBP , and TFIIA but not with TFIIEalpha in the GST pull - down assays'
p1705
(lp1706
I0
a(lp1707
I20
atp1708
a(I-1
S'Bcl3 specifically interacted with the general transcription factors TFIIB , TBP , and TFIIA but not with TFIIEalpha in the GST pull - down assays'
p1709
(lp1710
I8
a(lp1711
I13
atp1712
a(I-1
S'Bcl3 specifically interacted with the general transcription factors TFIIB , TBP , and TFIIA but not with TFIIEalpha in the GST pull - down assays'
p1713
(lp1714
I8
a(lp1715
I20
atp1716
a(I-1
S'Bcl3 specifically interacted with the general transcription factors TFIIB , TBP , and TFIIA but not with TFIIEalpha in the GST pull - down assays'
p1717
(lp1718
I13
a(lp1719
I20
atp1720
a(I-1
S'TBP and TFIIA , however , were not able to interact with IkappaBbeta'
p1721
(lp1722
I2
a(lp1723
I12
atp1724
a(I-1
S'Accordingly , Bcl3 coactivated the 9 - cis - RA - induced transactivations of RXR , in contrast to the inhibitory actions of IkappaBbeta'
p1725
(lp1726
I2
a(lp1727
I23
atp1728
a(I-1
S'In addition , coexpression of SRC - 1 but not p300 further stimulated the Bcl3 - mediated enhancement of the 9 - cis - RA - induced transactivations of RXR'
p1729
(lp1730
I5
aI6
aI7
a(lp1731
I10
atp1732
a.